{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1194865, "items": [{"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T03:52:00Z", "timestamp": 1575172320670}, "reference-count": 19, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 8705, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1991, 11]]}, "DOI": "10.1111/j.1349-7006.1991.tb01780.x", "type": "journal-article", "created": {"date-parts": [[2005, 8, 25]], "date-time": "2005-08-25T08:31:51Z", "timestamp": 1124958711000}, "page": "1199-1202", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Effects of Hormones on Tumor Growth and Immunoreactive Insulin-like Growth Factor-1 of Estrogen Receptor-positive Human Breast Cancer (MCF-7) Transplanted in Nude Mice"], "prefix": "10.1111", "volume": "82", "author": [{"given": "Masakuni", "family": "Noguchi", "sequence": "first", "affiliation": []}, {"given": "Naohiro", "family": "Koyasaki", "sequence": "additional", "affiliation": []}, {"given": "Itsuo", "family": "Miyazaki", "sequence": "additional", "affiliation": []}, {"given": "Yuji", "family": "Yuji", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2005, 8, 25]]}, "reference": [{"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1007/BF01806790", "article-title": "Autocrine and paracrine growth regulation of human breast cancer", "volume": "7", "author": "Lippman", "year": "1986", "journal-title": "Breast Cancer Res. Treat."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB2|cit2", "first-page": "2122", "article-title": "Somatomedin C receptors and growth effects in human breast cells maintained in long-term tissue culture", "volume": "44", "author": "Furlanetto", "year": "1984", "journal-title": "Cancer Res."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB3|cit3", "first-page": "4613", "article-title": "Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells", "volume": "46", "author": "Huff", "year": "1986", "journal-title": "Cancer Res."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1540", "DOI": "10.1126/science.3715461", "article-title": "Estrogen induced growth factors of breast cancer cells partially replace estrogen to promote tumor growth", "volume": "232", "author": "Dickson", "year": "1986", "journal-title": "Science"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB5|cit5", "first-page": "2481", "article-title": "Partial characterization of insulin-like growth factor I in primary human lung cancers using immunohistochemical and receptor autoradigraphic techniques", "volume": "50", "author": "Shigematsu", "year": "1990", "journal-title": "Cancer Res."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1210/mend-3-3-509", "article-title": "Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer", "volume": "3", "author": "Yee", "year": "1989", "journal-title": "Mol. Endocrinol"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/0378-5122(88)90094-1", "article-title": "Growth hormone and somatomedin C during postmenopausal replacement therapy with oestrogen alone and in combination with an antioestrogen", "volume": "9", "author": "Fr\u00f6hlander", "year": "1988", "journal-title": "Maturitas"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1210/jcem-63-2-424", "article-title": "Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement", "volume": "63", "author": "Dawson-Hughes", "year": "1986", "journal-title": "J. Clin. Endocrinol. Metab."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB9|cit9", "author": "Nichols Institute Diagnostics", "first-page": "1", "year": "1983", "volume-title": "Somatomedin-C Radioimmunoassay Kit for the Quantitative Determination of Somatomedin-C Levels in Human Plasma"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1210/endo-113-1-297", "article-title": "Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status", "volume": "113", "author": "Schwander", "year": "1983", "journal-title": "Endocrinology"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "390", "DOI": "10.1530/acta.0.1040390", "article-title": "Acute effects of growth hormone administration: vitamin A and visceral protein concentrations", "volume": "104", "author": "Kemp", "year": "1983", "journal-title": "Acta Endocrinol"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "1279", "DOI": "10.1126/science.6262917", "article-title": "Somatomedin-C mediates growth hormone negative feed back by effects on both the hypothalamus and the pituitary", "volume": "212", "author": "Berelowitz", "year": "1981", "journal-title": "Science"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1002/pros.2990100407", "article-title": "Steroid-sensitive proteins, growth hormone and somatomedin C in prostatic cancer: effects of parenteral and oral estrogen therapy", "volume": "10", "author": "Stege", "year": "1987", "journal-title": "Prostate"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1002/jcp.1041440104", "article-title": "Altered cell cycle responses to insulin-like growth factor 1, but not platelet-derived growth factor and epidermal growth factor in senscing human fibroblasts", "volume": "144", "author": "Chen", "year": "1990", "journal-title": "J. Cell. Physiol"}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1007/BF01807279", "article-title": "Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model", "volume": "11", "author": "Osborne", "year": "1988", "journal-title": "Breast Cancer Res, Treat."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1418", "DOI": "10.1172/JCI114315", "article-title": "Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice", "volume": "84", "author": "Arteaga", "year": "1989", "journal-title": "J. Clin. Invest."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB17|cit17", "first-page": "1343", "article-title": "Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer", "volume": "48", "author": "Pekonen", "year": "1988", "journal-title": "Cancer Res."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB18|cit18", "first-page": "6429", "article-title": "Insulin-like growth factor 1 receptor (IGF1-R) in human breast cancer. Relation to estradiol and progesterone receptors", "volume": "48", "author": "Peyrat", "year": "1988", "journal-title": "Cancer Res."}, {"key": "10.1111/j.1349-7006.1991.tb01780.x-BIB19|cit19", "first-page": "6931", "article-title": "Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer", "volume": "50", "author": "Bonneterre", "year": "1990", "journal-title": "Cancer Res."}], "container-title": ["Japanese Journal of Cancer Research"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.1991.tb01780.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T07:58:55Z", "timestamp": 1552895935000}, "score": 98.51943, "issued": {"date-parts": [[1991, 11]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[1991, 11]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1111/j.1349-7006.1991.tb01780.x", "relation": {"cites": []}, "ISSN": ["0910-5050"], "issn-type": [{"value": "0910-5050", "type": "print"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:39:57Z", "timestamp": 1574152797417}, "reference-count": 44, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1993, 3, 1]], "date-time": "1993-03-01T00:00:00Z", "timestamp": 730944000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular and Cellular Endocrinology"], "published-print": {"date-parts": [[1993, 3]]}, "DOI": "10.1016/0303-7207(93)90076-v", "type": "journal-article", "created": {"date-parts": [[2003, 2, 12]], "date-time": "2003-02-12T08:52:01Z", "timestamp": 1045039921000}, "page": "69-76", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Influence of hormones on tumor growth, cell kinetics, estrogen receptor and insulin-like growth factor-I-related protein of human breast cancer (MCF-7) cells transplanted in nude mice"], "prefix": "10.1016", "volume": "92", "author": [{"given": "M.", "family": "Noguchi", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Thomas", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Koyasaki", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Ohta", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Taniya", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Kitagawa", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Miyazaki", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Mizukami", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Molecular and Cellular Endocrinology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:030372079390076V?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:030372079390076V?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 28]], "date-time": "2019-03-28T05:22:19Z", "timestamp": 1553750539000}, "score": 83.73547, "issued": {"date-parts": [[1993, 3]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[1993, 3]]}, "issue": "1"}, "alternative-id": ["030372079390076V"], "URL": "http://dx.doi.org/10.1016/0303-7207(93)90076-v", "ISSN": ["0303-7207"], "issn-type": [{"value": "0303-7207", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:49:15Z", "timestamp": 1574484555716}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2011, 12, 15]]}, "DOI": "10.1158/0008-5472.sabcs11-p4-02-11", "type": "proceedings-article", "created": {"date-parts": [[2012, 6, 27]], "date-time": "2012-06-27T14:33:36Z", "timestamp": 1340807616000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P4-02-11: Insulin-Like Growth Factor I Promotes Estrogen Receptor Positive Breast Cancer Cell Proliferation, in Part, through CYP1A1 Signaling."], "prefix": "10.1158", "author": [{"given": "M", "family": "Rodriguez", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Becker", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Yee", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Potter", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 13]]}, "event": {"name": "Abstracts: Thirty-Fourth Annual CTRC\u2010AACR San Antonio Breast Cancer Symposium\u2010\u2010 Dec 6\u201010, 2011; San Antonio, TX"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.SABCS11-P4-02-11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T21:35:04Z", "timestamp": 1558215304000}, "score": 53.358192, "issued": {"date-parts": [[2011, 12, 15]]}, "references-count": 0, "alternative-id": ["10.1158/0008-5472.SABCS11-P4-02-11"], "URL": "http://dx.doi.org/10.1158/0008-5472.sabcs11-p4-02-11"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:32:12Z", "timestamp": 1574821932116}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 7, 1]]}, "DOI": "10.21236/ada420347", "type": "report", "created": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T17:28:23Z", "timestamp": 1502472503000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Insulin-Like Growth Factor Binding Protein-1 Interacts with Integrins to Inhibit Insulin-Like Growth Factor-Induced Breast Cancer Growth and Migration"], "prefix": "10.21236", "author": [{"given": "Jennifer M.", "family": "Gross", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T17:28:23Z", "timestamp": 1502472503000}, "score": 53.324856, "subtitle": [""], "issued": {"date-parts": [[2003, 7, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada420347"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T03:41:25Z", "timestamp": 1574307685780}, "reference-count": 94, "publisher": "Cambridge University Press (CUP)", "issue": "4", "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2009, 4, 1]], "date-time": "2009-04-01T00:00:00Z", "timestamp": 1238544000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Online"], "published-print": {"date-parts": [[2009, 4]]}, "DOI": "10.1017/s1470903109990058", "type": "journal-article", "created": {"date-parts": [[2009, 6, 18]], "date-time": "2009-06-18T09:03:21Z", "timestamp": 1245315801000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Drugs targeting insulin-like growth factor 1 receptor"], "prefix": "10.1017", "volume": "12", "author": [{"given": "T.", "family": "Mayer", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "Harris", "sequence": "additional", "affiliation": []}, {"given": "M. P.", "family": "DiGiovanna", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2009, 4, 1]]}, "reference": [{"key": "S1470903109990058_ref90", "DOI": "10.1046/j.1365-2141.2000.02047.x", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref88", "DOI": "10.1038/sj.bjc.6602963", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref87", "doi-asserted-by": "crossref", "first-page": "2503", "DOI": "10.1002/j.1460-2075.1986.tb04528.x", "article-title": "Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity", "volume": "5", "author": "Ullrich", "year": "1986", "journal-title": "EMBO J"}, {"key": "S1470903109990058_ref85", "DOI": "10.1007/BF00418267", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref91", "DOI": "10.1016/S0006-8993(96)01186-9", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref84", "DOI": "10.2337/diab.45.1.91", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref79", "unstructured": "79. Dong J , Tamraz S , Berquist L , et al. BIIB022, a human antibody targeting human insulin-like growth factor-1 receptor (IGF-1R), enhances the anti-tumor activities of Tarceva in non-small cell lung carcinoma (NSCLC) and rapamycin in sarcoma cell lines. AACR Annual Meeting 2008: abstract 4002."}, {"key": "S1470903109990058_ref74", "DOI": "10.1200/JCO.2006.08.8898", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref73", "author": "Sarantpoulos", "volume": "26", "year": "2008", "article-title": "A phase IB study of AMG 479, a type 1 insulin-like growth factor receptor (IGF-1R) antibody, in combination with panitumumab (P) or gemcitabine (G)", "journal-title": "J Clin Oncol"}, {"key": "S1470903109990058_ref71", "DOI": "10.1200/jco.2008.26.15_suppl.3519", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref77", "unstructured": "77. Higano C , Yu E , Whiting S , et al. A phase I, first in man study of weekly IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid tumors. Prostate Cancer Symposium, American Society of Clinical Oncology, Orlando, FL, USA, 2007: abstract 269.", "DOI": "10.1016/S1359-6349(06)70653-X", "doi-asserted-by": "crossref"}, {"key": "S1470903109990058_ref70", "DOI": "10.1200/jco.2008.26.15_suppl.3520", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref69", "DOI": "10.1200/jco.2008.26.15_suppl.8015", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref68", "DOI": "10.1200/JCO.2007.15.9319", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref62", "DOI": "10.1158/1078-0432.CCR-04-1070", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref61", "first-page": "8912", "article-title": "A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo", "volume": "63", "author": "Burtrum", "year": "2003", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref58", "DOI": "10.1200/jco.2008.26.15_suppl.14622", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref67", "DOI": "10.1158/1078-0432.CCR-07-1118", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref56", "DOI": "10.1158/1078-0432.CCR-06-1518", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref55", "DOI": "10.1158/1535-7163.MCT-07-0070", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref53", "DOI": "10.2325/jbcs.977", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref66", "DOI": "10.1158/1535-7163.MCT-05-0048", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref52", "DOI": "10.1158/0008-5472.CAN-05-1107", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref50", "DOI": "10.1016/S1535-6108(04)00050-9", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref49", "DOI": "10.1074/jbc.M305490200", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref48", "DOI": "10.1021/bi001516y", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref57", "DOI": "10.1158/1078-0432.CCR-06-1479", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref17", "DOI": "10.1016/S0140-6736(04)16044-3", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref26", "first-page": "2037", "article-title": "Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780", "volume": "2", "author": "Huynh", "year": "1996", "journal-title": "Clin Cancer Res"}, {"key": "S1470903109990058_ref92", "DOI": "10.1074/jbc.273.36.22877", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref39", "DOI": "10.1093/jnci/93.24.1852", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref22", "DOI": "10.1172/JCI114315", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref41", "DOI": "10.1038/sj.bjc.6602090", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref16", "first-page": "3079", "article-title": "Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation", "volume": "57", "author": "Turner", "year": "1997", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref20", "DOI": "10.1158/1055-9965.EPI-04-0561", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref13", "first-page": "6931", "article-title": "Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer", "volume": "50", "author": "Bonneterre", "year": "1990", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref81", "DOI": "10.1158/1535-7163.MCT-05-0397", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref1", "DOI": "10.1038/nrc1387", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref65", "first-page": "627", "article-title": "A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I", "volume": "63", "author": "Sachdev", "year": "2003", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref12", "author": "Merrick", "volume": "25", "year": "2007", "article-title": "High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically treated non-small cell lung cancer (NSCLC) patients (pts)", "journal-title": "J Clin Oncol"}, {"key": "S1470903109990058_ref14", "DOI": "10.1200/JCO.2007.13.4429", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref11", "first-page": "4369", "article-title": "Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility", "volume": "62", "author": "Zhang", "year": "2002", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref63", "DOI": "10.1002/ijc.20543", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref4", "first-page": "3513", "article-title": "Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer", "volume": "27", "author": "Subramanian", "year": "2007", "journal-title": "Anticancer Res"}, {"key": "S1470903109990058_ref40", "DOI": "10.1158/0008-5472.CAN-04-3841", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref15", "DOI": "10.1111/j.1524-4741.2008.00572.x", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref8", "first-page": "1159", "article-title": "Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer", "volume": "58", "author": "Resnik", "year": "1998", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref80", "DOI": "10.1158/0008-5472.CAN-03-2522", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref3", "first-page": "290", "article-title": "Insulin-like growth factors and breast cancer", "volume": "26", "author": "F\u00fcrstenberger", "year": "2003", "journal-title": "Onkologie"}, {"key": "S1470903109990058_ref94", "DOI": "10.1158/1078-0432.CCR-04-1544", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref76", "DOI": "10.1158/1078-0432.CCR-07-1109", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref10", "first-page": "3353", "article-title": "A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer", "volume": "58", "author": "Dunn", "year": "1998", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref82", "DOI": "10.1016/j.ejca.2007.03.003", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref78", "DOI": "10.1200/jco.2008.26.15_suppl.3582", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref36", "DOI": "10.1074/jbc.M306156200", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref37", "first-page": "1509", "article-title": "Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes", "volume": "36", "author": "Hallak", "year": "2002", "journal-title": "Hepatology"}, {"key": "S1470903109990058_ref93", "author": "Huang", "volume": "25", "year": "2007", "article-title": "Identification of sensitivity markers for BMS-536924, an inhibitor for insulin-like growth factor-1 receptor", "journal-title": "J Clin Oncol"}, {"key": "S1470903109990058_ref5", "DOI": "10.1158/1535-7163.MCT-06-0080", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref86", "DOI": "10.1042/bj2700383", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref6", "DOI": "10.1016/j.ejca.2004.06.015", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref72", "unstructured": "72. Beltran P , Mitchell P , Moody G , et al. AMG-479, a fully human anti IGF-1 receptor antibody, inhibits PI3K/Akt signaling and exerts potent antitumor effects in combination with EGF-R inhibitors in pancreatic xenograft models. Gastrointestinal Cancers Symposium, American Society of Clinical Oncology, Orlando, FL, USA, 2007: abstract 208."}, {"key": "S1470903109990058_ref43", "DOI": "10.1158/1078-0432.CCR-06-1304", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref83", "DOI": "10.1210/endo.136.10.7664648", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref9", "DOI": "10.1128/MCB.01315-06", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref23", "first-page": "1349", "article-title": "Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells", "volume": "1", "author": "Hailey", "year": "2002", "journal-title": "Mol Cancer Ther"}, {"key": "S1470903109990058_ref19", "DOI": "10.1677/erc.1.01149", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref25", "DOI": "10.1126/science.270.5241.1491", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref64", "first-page": "5073", "article-title": "An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation", "volume": "63", "author": "Maloney", "year": "2003", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref24", "DOI": "10.1007/BF01833338", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref27", "DOI": "10.1210/mend.13.5.0274", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref89", "DOI": "10.1007/s10911-006-9010-8", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref28", "DOI": "10.1677/joe.0.1520039", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref60", "unstructured": "60. Mulvihill M , Qun-Sheng J , Rosenfeld-Franklin M , et al. The discovery of OSI-906: a novel, potent, orally bioavailable imidazopyrazine-derived insulin-like growth factor-I receptor (IGF-1R) inhibitor with antitumor activity. AACR Annual Meeting 2008: abstract 4893."}, {"key": "S1470903109990058_ref29", "DOI": "10.1016/S0959-8049(98)00428-6", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref30", "DOI": "10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref54", "DOI": "10.1016/S1535-6108(04)00051-0", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref51", "DOI": "10.1158/1078-0432.CCR-05-1778", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref33", "DOI": "10.1677/erc.1.00799", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref21", "DOI": "10.1158/0008-5472.CAN-04-4602", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref31", "doi-asserted-by": "crossref", "first-page": "836", "DOI": "10.1055/s-2004-814145", "article-title": "Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo", "volume": "35", "author": "Ye", "year": "2003", "journal-title": "Horm Metab Res"}, {"key": "S1470903109990058_ref75", "author": "Rodon", "volume": "25", "year": "2007", "article-title": "A phase I study of q3W R1507, a human monoclonal antibody IGF-1R antagonist in patients with advanced cancer", "journal-title": "J Clin Oncol"}, {"key": "S1470903109990058_ref32", "DOI": "10.1210/endo.140.7.6766", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref18", "first-page": "3744", "article-title": "Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density", "volume": "60", "author": "Byrne", "year": "2000", "journal-title": "Cancer Res"}, {"key": "S1470903109990058_ref34", "DOI": "10.1038/sj.onc.1203028", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref47", "DOI": "10.1158/1535-7163.MCT-06-0423", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref38", "first-page": "521", "article-title": "Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells", "volume": "8", "author": "Camirand", "year": "2002", "journal-title": "Med Sci Monit"}, {"key": "S1470903109990058_ref35", "DOI": "10.1038/sj.onc.1204050", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref42", "DOI": "10.1007/s00432-005-0038-8", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref7", "DOI": "10.1074/jbc.M305403200", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref44", "author": "Harris", "volume": "82", "year": "2003", "article-title": "Response to Herceptin and chemotherapy in Herceptin-na\u00efve patients with HER2 3+/FISH+ breast cancer is modified by pattern of expression of insulin-like growth factor-I receptor (IGF-IR) but not epidermal growth factor (EGFR)", "journal-title": "Breast Cancer Res Treat"}, {"key": "S1470903109990058_ref59", "DOI": "10.1021/jm050392q", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref2", "DOI": "10.1038/sj.onc.1206772", "doi-asserted-by": "publisher"}, {"key": "S1470903109990058_ref45", "author": "DiGiovanna", "volume": "47", "year": "2006", "article-title": "Combinations of HER2, estrogen receptor (ER) and IGF-I receptor (IGF1R) inhibitors induce apoptosis in breast cancer cells: dramatic effects of HER2 inhibitors on non-overexpressing cells", "journal-title": "Proc Amer Assoc Cancer Res"}, {"key": "S1470903109990058_ref46", "DOI": "10.1158/0008-5472.CAN-07-5935", "doi-asserted-by": "publisher"}], "container-title": ["Breast Cancer Online"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S1470903109990058", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 20]], "date-time": "2019-05-20T23:57:36Z", "timestamp": 1558396656000}, "score": 50.386147, "issued": {"date-parts": [[2009, 4]]}, "references-count": 94, "journal-issue": {"published-print": {"date-parts": [[2009, 4]]}, "issue": "4"}, "alternative-id": ["S1470903109990058"], "URL": "http://dx.doi.org/10.1017/s1470903109990058", "relation": {"cites": []}, "ISSN": ["1470-9031"], "issn-type": [{"value": "1470-9031", "type": "electronic"}], "article-number": "e7"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:03:34Z", "timestamp": 1574489014218}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 2, 1]], "date-time": "1996-02-01T00:00:00Z", "timestamp": 823132800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Cancer"], "published-print": {"date-parts": [[1996, 2]]}, "DOI": "10.1038/bjc.1996.84", "type": "journal-article", "created": {"date-parts": [[2011, 1, 14]], "date-time": "2011-01-14T11:35:49Z", "timestamp": 1295004949000}, "page": "477-481", "source": "Crossref", "is-referenced-by-count": 21, "title": ["Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression"], "prefix": "10.1038", "volume": "73", "author": [{"given": "HW", "family": "van den Berg", "sequence": "first", "affiliation": []}, {"given": "D", "family": "Claffie", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Boylan", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "McKillen", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Lynch", "sequence": "additional", "affiliation": []}, {"given": "B", "family": "McKibben", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["British Journal of Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/bjc199684.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc199684", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/bjc199684.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T21:13:24Z", "timestamp": 1552770804000}, "score": 49.899513, "issued": {"date-parts": [[1996, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 2]]}, "issue": "4"}, "alternative-id": ["BFbjc199684"], "URL": "http://dx.doi.org/10.1038/bjc.1996.84", "ISSN": ["0007-0920", "1532-1827"], "issn-type": [{"value": "0007-0920", "type": "print"}, {"value": "1532-1827", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T08:33:28Z", "timestamp": 1575448408365}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Oncol"], "DOI": "10.3892/ijo.15.3.589", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:25:34Z", "timestamp": 1394436334000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins."], "prefix": "10.3892", "author": [{"given": "F", "family": "Rozen", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Pollak", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[1999, 9, 1]]}, "container-title": ["International Journal of Oncology"], "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.15.3.589/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T10:08:14Z", "timestamp": 1493287694000}, "score": 49.572296, "issued": {"date-parts": [[1999, 9, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/ijo.15.3.589", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:41:38Z", "timestamp": 1574113298797}, "reference-count": 0, "publisher": "The Endocrine Society", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Molecular Endocrinology"], "published-print": {"date-parts": [[1996, 3, 1]]}, "DOI": "10.1210/me.10.3.286", "type": "journal-article", "created": {"date-parts": [[2004, 2, 23]], "date-time": "2004-02-23T23:40:41Z", "timestamp": 1077579641000}, "page": "286-297", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells"], "prefix": "10.1210", "volume": "10", "author": [{"given": "M. J.", "family": "Ellis", "sequence": "first", "affiliation": []}], "member": "80", "container-title": ["Molecular Endocrinology"], "language": "en", "link": [{"URL": "http://press.endocrine.org/doi/full/10.1210/mend.10.3.8833657", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 2]], "date-time": "2016-12-02T22:48:20Z", "timestamp": 1480718900000}, "score": 49.47673, "issued": {"date-parts": [[1996, 3, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 3, 1]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1210/me.10.3.286", "ISSN": ["0888-8809"], "issn-type": [{"value": "0888-8809", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:29:56Z", "timestamp": 1574486996286}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 1, 15]]}, "DOI": "10.1158/0008-5472.sabcs-3044", "type": "proceedings-article", "created": {"date-parts": [[2010, 12, 30]], "date-time": "2010-12-30T23:31:29Z", "timestamp": 1293751889000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Co-targeting leptin and insulin-like growth factor I signaling: dramatic effects of epidermal growth factor receptor inhibitors on triple negative breast cancer cells."], "prefix": "10.1158", "author": [{"given": "NK", "family": "Saxena", "sequence": "first", "affiliation": []}, {"given": "LT", "family": "Smith", "sequence": "additional", "affiliation": []}, {"given": "BB", "family": "Knight", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Sharma", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Sharma", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 7]]}, "event": {"name": "CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.SABCS-3044", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T22:19:31Z", "timestamp": 1558217971000}, "score": 49.290134, "issued": {"date-parts": [[2009, 1, 15]]}, "references-count": 0, "alternative-id": ["10.1158/0008-5472.SABCS-3044"], "URL": "http://dx.doi.org/10.1158/0008-5472.sabcs-3044"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T23:10:48Z", "timestamp": 1574118648676}, "reference-count": 16, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1981, 12, 1]], "date-time": "1981-12-01T00:00:00Z", "timestamp": 376012800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Letters"], "published-print": {"date-parts": [[1981, 12]]}, "DOI": "10.1016/0304-3835(81)90160-9", "type": "journal-article", "created": {"date-parts": [[2004, 4, 17]], "date-time": "2004-04-17T18:47:25Z", "timestamp": 1082227645000}, "page": "309-316", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Estrogen induced growth of human breast cancer cells (MCF-7) in athymic nude mice is enhanced by secretions from a transplantable pituitary tumor"], "prefix": "10.1016", "volume": "14", "author": [{"given": "Clifford W.", "family": "Welsch", "sequence": "first", "affiliation": []}, {"given": "Esther L.", "family": "Swim", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Jean McManus", "sequence": "additional", "affiliation": []}, {"given": "Alice C.", "family": "White", "sequence": "additional", "affiliation": []}, {"given": "Charles M.", "family": "McGrath", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0304383581901609?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0304383581901609?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 13]], "date-time": "2019-02-13T12:00:57Z", "timestamp": 1550059257000}, "score": 48.628937, "issued": {"date-parts": [[1981, 12]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[1981, 12]]}, "issue": "3"}, "alternative-id": ["0304383581901609"], "URL": "http://dx.doi.org/10.1016/0304-3835(81)90160-9", "ISSN": ["0304-3835"], "issn-type": [{"value": "0304-3835", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:51:53Z", "timestamp": 1574398313742}, "publisher-location": "Boston, MA", "reference-count": 108, "publisher": "Springer US", "isbn-type": [{"value": "9781461405979", "type": "print"}, {"value": "9781461405986", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012]]}, "DOI": "10.1007/978-1-4614-0598-6_11", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 13]], "date-time": "2011-09-13T21:31:37Z", "timestamp": 1315949497000}, "page": "215-229", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Targeting Insulin-Like Growth Factor Receptor 1 (IGF-1R) and Insulin Receptor Signaling by Tyrosine Kinase Inhibitors in Cancer"], "prefix": "10.1007", "author": [{"given": "Joan M.", "family": "Carboni", "sequence": "first", "affiliation": []}, {"given": "Mark", "family": "Wittman", "sequence": "additional", "affiliation": []}, {"given": "Fei", "family": "Huang", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 8, 10]]}, "reference": [{"key": "11_CR1_11", "unstructured": "Andrews DW, et al. (2001). J Clin Oncol 19(8): 2189\u2013200."}, {"issue": "22", "key": "11_CR2_11", "first-page": "6237", "volume": "49", "author": "CL Arteaga", "year": "1989", "unstructured": "Arteaga CL and Osborne CK (1989). Cancer Res 49(22): 6237\u201341.", "journal-title": "pe=\"Underline\">Cancer Res"}, {"key": "11_CR3_11", "unstructured": "Beech DJ, et al. (2001). Oncol Rep 8(2): 325\u20139."}, {"issue": "7", "key": "11_CR4_11", "first-page": "671", "volume": "13", "author": "A Belfiore", "year": "2007", "unstructured": "Belfiore A (2007). Curr Pharm Des 13(7): 671\u201386.", "journal-title": "pe=\"Underline\">Curr Pharm Des"}, {"key": "11_CR5_11", "unstructured": "Byron SA, et al. (2006). Br J Cancer 95(9): 1220\u20138.", "DOI": "10.1038/sj.bjc.6603354", "doi-asserted-by": "crossref"}, {"key": "11_CR6_11", "unstructured": "Camirand A, et al. (2005). Breast Cancer Res 7(4): R570\u20139.", "DOI": "10.1186/bcr1028", "doi-asserted-by": "crossref"}, {"key": "11_CR7_11", "unstructured": "Campbell RA, et al. (2001). J Biol Chem 276(13): 9817\u201324.", "DOI": "10.1074/jbc.M010840200", "doi-asserted-by": "crossref"}, {"key": "11_CR8_11", "unstructured": "Cao L, et al. (2008). Cancer Res 68(19): 8039\u201348.", "DOI": "10.1158/0008-5472.CAN-08-1712", "doi-asserted-by": "crossref"}, {"key": "11_CR9_11", "unstructured": "Carboni JM, et al. (2005). Cancer Res 65(9): 3781\u20137."}, {"key": "11_CR11_11", "unstructured": "Carboni JM, et al. (2009). Mol Cancer Ther 8(12): 3341\u20139."}, {"key": "11_CR12_11", "unstructured": "Carden CP, et al. (2009a). Clin Pharmacol Ther 85(2): 131\u20133.", "DOI": "10.1038/clpt.2008.223", "doi-asserted-by": "crossref"}, {"key": "11_CR13_11", "unstructured": "Carden CP, et al. (2009b). J Clin Oncol (Meeting Abstracts) 27(15S): Abstract 3544."}, {"key": "11_CR14_11", "doi-asserted-by": "crossref", "first-page": "3273", "DOI": "10.2741/2925", "volume": "13", "author": "AJ Casa", "year": "2008", "unstructured": "Casa AJ, et al. (2008). Frontiers in Bioscience 13: 3273\u201387.", "journal-title": "pe=\"Underline\">Frontiers in Bioscience"}, {"key": "11_CR15_11", "unstructured": "Chakraborty AK, et al. (2008). Cancer Res 68(5): 1538\u201345.", "DOI": "10.1158/0008-5472.CAN-07-5935", "doi-asserted-by": "crossref"}, {"key": "11_CR16_11", "unstructured": "Chan JM, et al. (1998). Science 279(5350): 563\u20136.", "DOI": "10.1126/science.279.5350.563", "doi-asserted-by": "crossref"}, {"key": "11_CR17_11", "unstructured": "Chu KC, et al. (2001). Cancer 92(1): 37\u201345.", "DOI": "10.1002/1097-0142(20010701)92:1<37::AID-CNCR1289>3.0.CO;2-F", "doi-asserted-by": "crossref"}, {"key": "11_CR18_11", "unstructured": "Clemens PL, et al. (2009). Molecular Cancer Therapeutics 8(12): Abstract A101."}, {"key": "11_CR19_11", "unstructured": "Cortes J, et al. (2008). ASH Annual Meeting Abstracts 112(11): Abstract 3232."}, {"key": "11_CR20_11", "unstructured": "Cosaceanu D, et al. (2007). Oncogene 26(17): 2423\u201334.", "DOI": "10.1038/sj.onc.1210037", "doi-asserted-by": "crossref"}, {"key": "11_CR21_11", "unstructured": "Cunningham MP, et al. (2006). Int J Oncol 28(2): 329\u201335."}, {"key": "11_CR22_11", "unstructured": "D\u2019Ambrosio C, et al. (1996). Cancer Res 56(17): 4013\u201320."}, {"key": "11_CR23_11", "unstructured": "D\u2019cunja J, et al. (2007). Eur J Cancer 43(10): 1581\u20139."}, {"key": "11_CR24_11", "unstructured": "Desai J, et al. (2010). J Clin Oncol (Meeting Abstracts) 28(7S): Abstract 3104."}, {"issue": "17", "key": "11_CR25_11", "doi-asserted-by": "crossref", "first-page": "5445", "DOI": "10.1158/1078-0432.CCR-08-2980", "volume": "15", "author": "C Desbois-Mouthon", "year": "2009", "unstructured": "Desbois-Mouthon C, et al. (2009). Clin Cancer Res 15(17): 5445\u201356.", "journal-title": "pe=\"Underline\">Clin Cancer Res"}, {"key": "11_CR26_11", "unstructured": "Dinchuk JE, et al. (2010). Endocrinology: manuscript submitted."}, {"key": "11_CR27_11", "unstructured": "Dunn SE, et al. (1997). Cancer Res 57(13): 2687\u201393.", "DOI": "10.3917/legi.013.0057", "doi-asserted-by": "crossref"}, {"issue": "10", "key": "11_CR28_11", "doi-asserted-by": "crossref", "first-page": "3788", "DOI": "10.1073/pnas.0409773102", "volume": "102", "author": "JA Engelman", "year": "2005", "unstructured": "Engelman JA, et al. (2005). Proc Natl Acad Sci USA. 102(10): 3788\u201393.", "journal-title": "pe=\"Underline\">Proc Natl Acad Sci USA."}, {"key": "11_CR29_11", "unstructured": "Frasca F, et al. (1999). Mol Cell Biol 19(5): 3278\u201388.", "DOI": "10.1128/MCB.19.5.3278", "doi-asserted-by": "crossref"}, {"key": "11_CR30_11", "unstructured": "Garcia-Echeverria C, et al. (2004). Cancer Cell 5(3): 231\u20139."}, {"key": "11_CR31_11", "unstructured": "Girnita A, et al. (2004). Cancer Res 64(1): 236\u201342.", "DOI": "10.1158/0008-5472.CAN-03-2522", "doi-asserted-by": "crossref"}, {"key": "11_CR32_11", "unstructured": "Gong Y, et al. (2009). J Clin Oncol (Meeting Abstracts) 27(15S): Abstract 8095."}, {"key": "11_CR33_11", "unstructured": "Gooch JL, et al. (1999). Breast Cancer Res Treat 56(1): 1\u201310.", "DOI": "10.1023/A:1006208721167", "doi-asserted-by": "crossref"}, {"key": "11_CR34_11", "unstructured": "Gualberto A and Pollak M (2009). Oncogene 28(34): 3009\u201321.", "DOI": "10.1038/onc.2009.172", "doi-asserted-by": "crossref"}, {"key": "11_CR35_11", "unstructured": "Haluska P, et al. (2006). Cancer Res 66(1): 362\u201371.", "DOI": "10.1158/0008-5472.CAN-05-1107", "doi-asserted-by": "crossref"}, {"key": "11_CR36_11", "unstructured": "Haluska P, et al. (2007). Proceedings from the 15th SPORE Investigators\u2019 Workshop."}, {"key": "11_CR37_11", "unstructured": "Haluska P, et al. (2008). Mol Cancer Ther 7(9): 2589\u201398.", "DOI": "10.1158/1535-7163.MCT-08-0493", "doi-asserted-by": "crossref"}, {"key": "11_CR38_11", "unstructured": "Haluska P, et al. (2009). 32nd San Antonio Breast Cancer Symposium."}, {"key": "11_CR39_11", "unstructured": "Harmenberg J, et al. (2009). Molecular Cancer Therapeutics 8(12): Abstract B256."}, {"key": "11_CR40_11", "unstructured": "Harris LN, et al. (2007). Clin Cancer Res. 13(4): 1198\u2013207."}, {"key": "11_CR41_11", "unstructured": "Harzstark AL, et al. (2007). J Clin Oncol 25(18S)."}, {"issue": "10", "key": "11_CR42_11", "first-page": "1032", "volume": "10", "author": "AW Hendrickson", "year": "2009", "unstructured": "Hendrickson AW and Haluska P (2009). Curr Opin Investig Drugs 10(10): 1032\u201340.", "journal-title": "pe=\"Underline\">Curr Opin Investig Drugs"}, {"issue": "1", "key": "11_CR43_11", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.2174/157489209787002515", "volume": "4", "author": "M Hewish", "year": "2009", "unstructured": "Hewish M, et al. (2009). Recent Pat Anticancer Drug Discov 4(1): 54\u201372.", "journal-title": "pe=\"Underline\">Recent Pat Anticancer Drug Discov"}, {"key": "11_CR44_11", "unstructured": "Hillerman SM, et al. (2010). Proceedings of the 101st Annual Meeting of the AACR; Abstract 363."}, {"key": "11_CR45_11", "unstructured": "Huang F, et al. (2009). Cancer Res 69(1): 161\u201370."}, {"key": "11_CR111_11", "unstructured": "Huang F, et al. (2010). Cancer Res 70(18): 7221\u201331.", "DOI": "10.1158/0008-5472.CAN-10-0391", "doi-asserted-by": "crossref"}, {"key": "11_CR46_11", "unstructured": "Hubbard RD and Wilsbacher JL (2007). ChemMedChem 2(1): 41\u20136.", "DOI": "10.1002/cmdc.200600174", "doi-asserted-by": "crossref"}, {"key": "11_CR47_11", "unstructured": "Ji QS, et al. (2007). Mol Cancer Ther 6(8): 2158\u201367."}, {"key": "11_CR48_11", "unstructured": "Jones HE, et al. (2004). Endocr Relat Cancer 11(4): 793\u2013814."}, {"key": "11_CR49_11", "unstructured": "Jones HE, et al. (2006). Br J Cancer 95(2): 172\u201380.", "DOI": "10.1038/sj.bjc.6603237", "doi-asserted-by": "crossref"}, {"key": "11_CR50_11", "unstructured": "Kalli KR, et al. (2002). Endocrinology 143(9): 3259\u201367.", "DOI": "10.1210/en.2001-211408", "doi-asserted-by": "crossref"}, {"key": "11_CR51_11", "unstructured": "Karp DD, et al. (2009). J Clin Oncol 27(15): 2516\u201322."}, {"key": "11_CR52_11", "unstructured": "Kim HJ, et al. (2007). Mol Cell Biol 27(8): 3165\u201375."}, {"key": "11_CR53_11", "unstructured": "Knowlden JM, et al. (2005). Endocrinology 146(11): 4609\u201318.", "DOI": "10.1210/en.2005-0247", "doi-asserted-by": "crossref"}, {"key": "11_CR54_11", "unstructured": "Kobayashi S, et al. (2005). N Engl J Med. 352(8): 786\u201392."}, {"key": "11_CR55_11", "unstructured": "Kostler WJ, et al. (2006). J Cancer Res Clin Oncol 132(1): 9\u201318.", "DOI": "10.1007/s00432-005-0038-8", "doi-asserted-by": "crossref"}, {"key": "11_CR56_11", "unstructured": "Lee AV, et al. (1997). J Endocrinol 152(1): 39\u201347.", "DOI": "10.1016/S0294-3506(97)87702-2", "doi-asserted-by": "crossref"}, {"key": "11_CR57_11", "unstructured": "Lee J, et al. (2007). Mol Pharmacol. 72(4): 1082\u201393."}, {"key": "11_CR58_11", "unstructured": "LeRoith D, et al. (1995). Ann Intern Med 122(1): 54\u20139.", "DOI": "10.7326/0003-4819-122-1-199501010-00009", "doi-asserted-by": "crossref"}, {"key": "11_CR59_11", "unstructured": "Li R, et al. (2009). J Med Chem 52(16): 4981\u20135004.", "DOI": "10.1021/jm9002395", "doi-asserted-by": "crossref"}, {"key": "11_CR60_11", "unstructured": "Lindsay CR, et al. (2009). J Clin Oncol (Meeting Abstracts) 27(15S): Abstract 2559."}, {"key": "11_CR61_11", "unstructured": "Litzenburger BC, et al. (2009). 32nd San Antonio Breast Cancer Symposium."}, {"key": "11_CR62_11", "unstructured": "Long L, et al. (1995). Cancer Res 55(5): 1006\u20139."}, {"key": "11_CR63_11", "unstructured": "Lu Y, et al. (2001). J Natl Cancer Inst 93(24): 1852\u20137.", "DOI": "10.1093/jnci/93.24.1852", "doi-asserted-by": "crossref"}, {"key": "11_CR64_11", "unstructured": "Macaulay VM, et al. (2001). Oncogene 20(30): 4029\u201340.", "DOI": "10.1038/sj.onc.1204565", "doi-asserted-by": "crossref"}, {"key": "11_CR65_11", "unstructured": "Maiso P, et al. (2008). Br J Haematol 141(4): 470\u201382.", "DOI": "10.1111/j.1365-2141.2008.07049.x", "doi-asserted-by": "crossref"}, {"key": "11_CR112_11", "unstructured": "Martins AS, et al. (2008). Cancer Res 68(15): 6260\u201370.", "DOI": "10.1158/0008-5472.CAN-07-3074", "doi-asserted-by": "crossref"}, {"key": "11_CR66_11", "unstructured": "Min Y, et al. (2005). Gut 54(5): 591\u2013600.", "DOI": "10.1136/gut.2004.048926", "doi-asserted-by": "crossref"}, {"key": "11_CR67_11", "unstructured": "Mitsiades CS, et al. (2004). Cancer Cell 5(3): 221\u201330.", "DOI": "10.1016/S1535-6108(04)00050-9", "doi-asserted-by": "crossref"}, {"key": "11_CR68_11", "unstructured": "Moller DE, et al. (1989). Mol Endocrinol 3(8): 1263\u20139."}, {"key": "11_CR69_11", "unstructured": "Morgillo F, et al. (2006). Cancer Res 66(20): 10100\u201311.", "DOI": "10.1158/0008-5472.CAN-06-1684", "doi-asserted-by": "crossref"}, {"key": "11_CR70_11", "unstructured": "Morgillo F, et al. (2007). Clin Cancer Res 13(9): 2795\u2013803.", "DOI": "10.1158/1078-0432.CCR-06-2077", "doi-asserted-by": "crossref"}, {"key": "11_CR71_11", "unstructured": "Mukohara T, et al. (2009). Cancer Lett 282(1): 14\u201324.", "DOI": "10.1016/j.canlet.2009.02.056", "doi-asserted-by": "crossref"}, {"key": "11_CR72_11", "unstructured": "Mulvihill M, et al. (2008). Proceedings of the 101st Annual Meeting of the AACR; Abstract 4893."}, {"key": "11_CR73_11", "unstructured": "Nahta R, et al. (2005). Cancer Res 65(23): 11118\u201328.", "DOI": "10.1158/0008-5472.CAN-04-3841", "doi-asserted-by": "crossref"}, {"key": "11_CR74_11", "unstructured": "Nahta R, et al. (2007). Mol Cancer Ther 6(2): 667\u20134.", "DOI": "10.1158/1535-7163.MCT-06-0423", "doi-asserted-by": "crossref"}, {"key": "11_CR75_11", "unstructured": "Nakamura S, et al. (1997). Exp Cell Res. 235(1): 287\u201394."}, {"key": "11_CR76_11", "unstructured": "Pandini G, et al. (1999). Clin Cancer Res 5(7): 1935\u201344."}, {"key": "11_CR77_11", "unstructured": "Pandini G, et al. (2002). J Biol Chem 277(42): 39684\u201395.", "DOI": "10.1074/jbc.M202766200", "doi-asserted-by": "crossref"}, {"key": "11_CR78_11", "unstructured": "Pao W, et al. (2005). PLoS Med. 2(3): e73.", "DOI": "10.1371/journal.pmed.0020073", "doi-asserted-by": "crossref"}, {"key": "11_CR79_11", "unstructured": "Perer ES, et al. (2000). J Surg Res 94(1): 1\u20135."}, {"issue": "4", "key": "11_CR80_11", "doi-asserted-by": "crossref", "first-page": "1676", "DOI": "10.1073/pnas.98.4.1676", "volume": "98", "author": "S Peretz", "year": "2001", "unstructured": "Peretz S, et al. (2001). Proc Natl Acad Sci U S A. 98(4): 1676\u201381.", "journal-title": "pe=\"Underline\">Proc Natl Acad Sci U S A."}, {"key": "11_CR81_11", "unstructured": "Peruzzi F, et al. (1999). Mol Cell Biol 19(10): 7203\u201315.", "DOI": "10.1128/MCB.19.10.7203", "doi-asserted-by": "crossref"}, {"key": "11_CR82_11", "unstructured": "Pietrzkowski Z, et al. (1993). Cancer Res 53(5): 1102\u20136."}, {"key": "11_CR83_11", "unstructured": "Pitts TM, et al. (2009). Molecular Cancer Therapeutics 8(12): Abstract A39."}, {"issue": "4", "key": "11_CR84_11", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1016/j.coph.2008.07.004", "volume": "8", "author": "M Pollak", "year": "2008", "unstructured": "Pollak M (2008). Curr Opin Pharmacol 8(4): 384\u201392.", "journal-title": "pe=\"Underline\">Curr Opin Pharmacol"}, {"key": "11_CR85_11", "unstructured": "Sciacca L, et al. (1999). Oncogene 18(15): 2471\u20139.", "DOI": "10.1038/sj.onc.1202600", "doi-asserted-by": "crossref"}, {"key": "11_CR86_11", "unstructured": "Sciacca L, et al. (2002). Oncogene 21(54): 8240\u201350.", "DOI": "10.1038/sj.onc.1206058", "doi-asserted-by": "crossref"}, {"key": "11_CR87_11", "unstructured": "Scotlandi K, et al. (2005). Cancer Res 65(9): 3868\u201376.", "DOI": "10.1158/0008-5472.CAN-04-3192", "doi-asserted-by": "crossref"}, {"key": "11_CR88_11", "unstructured": "Smith DC, et al. (2010). J Clin Oncol (Meeting Abstracts) 28(7S): Abstract 3105."}, {"key": "11_CR89_11", "unstructured": "Tan AC, et al. (2009). Molecular Cancer Therapeutics 8(12): Abstract C22."}, {"key": "11_CR90_11", "unstructured": "Turner BC, et al. (1997). Cancer Res 57(15): 3079\u201383.", "DOI": "10.3406/forem.1997.2203", "doi-asserted-by": "crossref"}, {"key": "11_CR91_11", "unstructured": "Ulanet DB, et al. (2010). Proc Natl Acad Sci USA."}, {"key": "11_CR92_11", "unstructured": "Valentinis B and Baserga R (2001). Mol Pathol 54(3): 133\u20137.", "DOI": "10.1136/mp.54.3.133", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "11_CR93_11", "doi-asserted-by": "crossref", "first-page": "748", "DOI": "10.2174/156800909789271495", "volume": "9", "author": "J Veeken", "year": "2009", "unstructured": "van der Veeken J, et al. (2009). Curr Cancer Drug Targets 9(6): 748\u201360.", "journal-title": "pe=\"Underline\">Curr Cancer Drug Targets"}, {"key": "11_CR94_11", "unstructured": "Velaparthi U, et al. (2008). J Med Chem 51(19): 5897\u2013900."}, {"key": "11_CR95_11", "unstructured": "Vella V, et al. (2002). J Clin Endocrinol Metab 87(1): 245\u201354."}, {"issue": "5", "key": "11_CR96_11", "first-page": "527", "volume": "3", "author": "GS Warshamana-Greene", "year": "2004", "unstructured": "Warshamana-Greene GS, et al. (2004). Mol Cancer Ther 3(5): 527\u201335.", "journal-title": "pe=\"Underline\">Mol Cancer Ther"}, {"issue": "4", "key": "11_CR97_11", "doi-asserted-by": "crossref", "first-page": "1563", "DOI": "10.1158/1078-0432.CCR-04-1544", "volume": "11", "author": "GS Warshamana-Greene", "year": "2005", "unstructured": "Warshamana-Greene GS, et al. (2005). Clin Cancer Res 11(4): 1563\u201371.", "journal-title": "pe=\"Underline\">Clin Cancer Res"}, {"key": "11_CR98_11", "unstructured": "Wen B, et al. (2001). Br J Cancer 85(12): 2017\u201321.", "DOI": "10.1038/sj/bjc/6692171", "doi-asserted-by": "crossref"}, {"issue": "4", "key": "11_CR99_11", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1007/s10911-008-9104-6", "volume": "13", "author": "SJ Weroha", "year": "2008", "unstructured": "Weroha SJ and Haluska P (2008). J Mammary Gland Biol Neoplasia 13(4): 471\u201383.", "journal-title": "pe=\"Underline\">J Mammary Gland Biol Neoplasia"}, {"key": "11_CR100_11", "unstructured": "Wittman MD, et al. (2009a). J Med Chem 52(23): 7360\u20133."}, {"key": "11_CR101_11", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/S0065-7743(09)04414-5", "volume": "44", "author": "MD Wittman", "year": "2009b", "unstructured": "Wittman MD, et al. (2009b). Annual Reports in Medicinal Chemistry 44: 281\u2013299.", "journal-title": "pe=\"Underline\">Annual Reports in Medicinal Chemistry"}, {"key": "11_CR102_11", "unstructured": "Zha J, et al. (2009). Mol Cancer Ther 8(8): 2110\u201321."}, {"key": "11_CR103_11", "unstructured": "Zhang H, et al. (2007). J Clin Invest. 117(8): 2051\u20138."}, {"key": "11_CR104_11", "unstructured": "Zhang H, et al. (2010). Oncogene in press."}, {"key": "11_CR105_11", "unstructured": "Zhou DJ, et al. (1990). Cancer Res 50(21): 6949\u201354."}, {"issue": "14", "key": "11_CR106_11", "doi-asserted-by": "crossref", "first-page": "4075", "DOI": "10.1016/j.bmcl.2008.05.104", "volume": "18", "author": "K Zimmermann", "year": "2008", "unstructured": "Zimmermann K, et al. (2008). Bioorg Med Chem Lett 18(14): 4075\u201380.", "journal-title": "pe=\"Underline\">Bioorg Med Chem Lett"}, {"key": "11_CR107_11", "unstructured": "Zimmermann K, et al. (2010). Bioorg Med Chem Lett 20(5): 1744\u20138."}], "container-title": ["Insulin-like Growth Factors and Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4614-0598-6_11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 15]], "date-time": "2019-06-15T13:07:16Z", "timestamp": 1560604036000}, "score": 48.500042, "issued": {"date-parts": [[2011, 8, 10]]}, "ISBN": ["9781461405979", "9781461405986"], "references-count": 108, "URL": "http://dx.doi.org/10.1007/978-1-4614-0598-6_11", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T08:09:12Z", "timestamp": 1574582952590}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "8", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2015, 4, 15]]}, "DOI": "10.1158/1078-0432.ccr-14-1748", "type": "journal-article", "created": {"date-parts": [[2015, 2, 18]], "date-time": "2015-02-18T06:07:53Z", "timestamp": 1424239673000}, "page": "1877-1887", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer"], "prefix": "10.1158", "volume": "21", "author": [{"given": "A. H.", "family": "Rosendahl", "sequence": "first", "affiliation": []}, {"given": "C. M.", "family": "Perks", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Zeng", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Markkula", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Simonsson", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Rose", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Ingvar", "sequence": "additional", "affiliation": []}, {"given": "J. M. P.", "family": "Holly", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Jernstrom", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2015, 2, 17]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-14-1748", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:21:58Z", "timestamp": 1482466918000}, "score": 48.49104, "issued": {"date-parts": [[2015, 2, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 4, 14]]}, "published-print": {"date-parts": [[2015, 4, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-14-1748", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:30:49Z", "timestamp": 1574094649612}, "reference-count": 31, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1998, 10, 1]], "date-time": "1998-10-01T00:00:00Z", "timestamp": 907200000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Letters"], "published-print": {"date-parts": [[1998, 10]]}, "DOI": "10.1016/s0304-3835(98)00171-2", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:00:40Z", "timestamp": 1027598440000}, "page": "107-112", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Enhanced angiogenesis and growth of 12-lipoxygenase gene-transfected MCF-7 human breast cancer cells in athymic nude mice"], "prefix": "10.1016", "volume": "132", "author": [{"given": "Jeanne M.", "family": "Connolly", "sequence": "first", "affiliation": []}, {"given": "David P.", "family": "Rose", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0304383598001712?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0304383598001712?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 1]], "date-time": "2019-05-01T04:51:04Z", "timestamp": 1556686264000}, "score": 48.078842, "issued": {"date-parts": [[1998, 10]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[1998, 10]]}, "issue": "1-2"}, "alternative-id": ["S0304383598001712"], "URL": "http://dx.doi.org/10.1016/s0304-3835(98)00171-2", "ISSN": ["0304-3835"], "issn-type": [{"value": "0304-3835", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T05:48:23Z", "timestamp": 1574401703306}, "reference-count": 52, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 9, 22]], "date-time": "2011-09-22T00:00:00Z", "timestamp": 1316649600000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2011, 10]]}, "DOI": "10.1186/bcr3018", "type": "journal-article", "created": {"date-parts": [[2011, 9, 22]], "date-time": "2011-09-22T18:18:40Z", "timestamp": 1316715520000}, "source": "Crossref", "is-referenced-by-count": 12, "title": ["erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines"], "prefix": "10.1186", "volume": "13", "author": [{"given": "Janice M", "family": "Knowlden", "sequence": "first", "affiliation": []}, {"given": "Julia MW", "family": "Gee", "sequence": "additional", "affiliation": []}, {"given": "Denise", "family": "Barrow", "sequence": "additional", "affiliation": []}, {"given": "John F", "family": "Robertson", "sequence": "additional", "affiliation": []}, {"given": "Ian O", "family": "Ellis", "sequence": "additional", "affiliation": []}, {"given": "Robert I", "family": "Nicholson", "sequence": "additional", "affiliation": []}, {"given": "Iain R", "family": "Hutcheson", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 9, 22]]}, "reference": [{"key": "2750_CR1", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1677/erc.0.0080197", "volume": "8", "author": "D Sachdev", "year": "2001", "unstructured": "Sachdev D, Yee D: The IGF system and breast cancer. Endocr Rel Cancer. 2001, 8: 197-209. 10.1677/erc.0.0080197.", "journal-title": "Endocr Rel Cancer"}, {"key": "2750_CR2", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1023/A:1009523501499", "volume": "5", "author": "E Surmacz", "year": "2000", "unstructured": "Surmacz E: Function of the IGF-I receptor in breast cancer. J Mammary Gland Biol Neoplasia. 2000, 5: 95-105. 10.1023/A:1009523501499.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "2750_CR3", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1007/s10911-008-9098-0", "volume": "13", "author": "DH Fagan", "year": "2008", "unstructured": "Fagan DH, Yee D: Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia. 2008, 13: 423-429. 10.1007/s10911-008-9098-0.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "2750_CR4", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1023/A:1005907101686", "volume": "47", "author": "E Surmacz", "year": "1998", "unstructured": "Surmacz E, Guvakova MA, Nolan MK, Nicosia RF, Sciacca L: Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res Treat. 1998, 47: 255-267. 10.1023/A:1005907101686.", "journal-title": "Breast Cancer Res Treat"}, {"key": "2750_CR5", "doi-asserted-by": "publisher", "first-page": "412", "DOI": "10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4", "volume": "183", "author": "LC Happerfield", "year": "1997", "unstructured": "Happerfield LC, Miles DW, Barnes DM, Thomsen LL, Smith P, Hanby A: The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. J Pathol. 1997, 183: 412-417. 10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4.", "journal-title": "J Pathol"}, {"issue": "Suppl 1", "key": "2750_CR6", "doi-asserted-by": "publisher", "first-page": "S99", "DOI": "10.1677/erc.1.01005", "volume": "12", "author": "JM Gee", "year": "2005", "unstructured": "Gee JM, Robertson JF, Gutteridge E, Ellis IO, Pinder SE, Rubini M, Nicholson RI: Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer. 2005, 12 (Suppl 1): S99-S111.", "journal-title": "Endocr Relat Cancer"}, {"key": "2750_CR7", "first-page": "21172", "volume": "265", "author": "AJ Stewart", "year": "1990", "unstructured": "Stewart AJ, Johnson MD, May FE, Westley BR: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem. 1990, 265: 21172-21178.", "journal-title": "J Biol Chem"}, {"key": "2750_CR8", "doi-asserted-by": "publisher", "first-page": "787", "DOI": "10.1210/mend.13.5.0274", "volume": "13", "author": "AV Lee", "year": "1999", "unstructured": "Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D: Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol. 1999, 13: 787-796. 10.1210/me.13.5.787.", "journal-title": "Mol Endocrinol"}, {"key": "2750_CR9", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1677/erc.0.0100331", "volume": "10", "author": "IH Hamelers", "year": "2003", "unstructured": "Hamelers IH, Steenbergh PH: Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer. 2003, 10: 331-345. 10.1677/erc.0.0100331.", "journal-title": "Endocr Relat Cancer"}, {"key": "2750_CR10", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1023/A:1009575518338", "volume": "5", "author": "D Yee", "year": "2000", "unstructured": "Yee D, Lee AV: Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia. 2000, 5: 107-115. 10.1023/A:1009575518338.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "2750_CR11", "first-page": "103", "volume": "3", "author": "RL Rocha", "year": "1997", "unstructured": "Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, Lee AV, Yee D: Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res. 1997, 3: 103-109.", "journal-title": "Clin Cancer Res"}, {"key": "2750_CR12", "first-page": "3079", "volume": "57", "author": "BC Turner", "year": "1997", "unstructured": "Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM: Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res. 1997, 57: 3079-3083.", "journal-title": "Cancer Res"}, {"key": "2750_CR13", "doi-asserted-by": "publisher", "first-page": "3009", "DOI": "10.1038/onc.2009.172", "volume": "28", "author": "A Gualberto", "year": "2009", "unstructured": "Gualberto A, Pollak M: Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions. Oncogene. 2009, 28: 3009-3021. 10.1038/onc.2009.172.", "journal-title": "Oncogene"}, {"key": "2750_CR14", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1007/BF02980074", "volume": "27", "author": "YH Lee", "year": "2004", "unstructured": "Lee YH, White MF: Insulin receptor substrate proteins and diabetes. Arch Pharm Res. 2004, 27: 361-370. 10.1007/BF02980074.", "journal-title": "Arch Pharm Res"}, {"issue": "Suppl 2", "key": "2750_CR15", "doi-asserted-by": "publisher", "first-page": "S2", "DOI": "10.1007/s001250051387", "volume": "40", "author": "MF White", "year": "1997", "unstructured": "White MF: The insulin signalling system and the IRS proteins. Diabetologia. 1997, 40 (Suppl 2): S2-S17.", "journal-title": "Diabetologia"}, {"key": "2750_CR16", "first-page": "2903", "volume": "114", "author": "MA Lawlor", "year": "2001", "unstructured": "Lawlor MA, Alessi DR: PKB/Akt: a key mediator of cell proliferation, survival and insulin responses?. J Cell Sci. 2001, 114: 2903-2910.", "journal-title": "J Cell Sci"}, {"key": "2750_CR17", "doi-asserted-by": "publisher", "first-page": "381", "DOI": "10.1016/S0898-6568(01)00271-6", "volume": "14", "author": "KM Nicholson", "year": "2002", "unstructured": "Nicholson KM, Anderson NG: The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002, 14: 381-395. 10.1016/S0898-6568(01)00271-6.", "journal-title": "Cell Signal"}, {"key": "2750_CR18", "first-page": "6035", "volume": "62", "author": "Q Chang", "year": "2002", "unstructured": "Chang Q, Li Y, White MF, Fletcher JA, Xiao S: Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res. 2002, 62: 6035-6038.", "journal-title": "Cancer Res"}, {"key": "2750_CR19", "doi-asserted-by": "publisher", "first-page": "9302", "DOI": "10.1128/MCB.00260-06", "volume": "26", "author": "RK Dearth", "year": "2006", "unstructured": "Dearth RK, Cui X, Kim HJ, Kuiatse I, Lawrence NA, Zhang X, Divisova J, Britton OL, Mohsin S, Allred DC, Hadsell DL, Lee AV: Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate (IRS)-1 or IRS-2. Mol Cell Biol. 2006, 26: 9302-9314. 10.1128/MCB.00260-06.", "journal-title": "Mol Cell Biol"}, {"key": "2750_CR20", "first-page": "361", "volume": "52", "author": "M Koda", "year": "2005", "unstructured": "Koda M, Sulkowska M, Kanczuga-Koda L, Golaszewska J, Kisielewski W, Baltaziak M, Wincewicz A, Sulkowski S: Expression of the insulin receptor substrate 1 in primary tumors and lymph node metastases in breast cancer: correlations with Bcl-xL and Bax proteins. Neoplasma. 2005, 52: 361-363.", "journal-title": "Neoplasma"}, {"key": "2750_CR21", "doi-asserted-by": "publisher", "first-page": "705", "DOI": "10.4161/cc.6.6.4035", "volume": "6", "author": "RK Dearth", "year": "2007", "unstructured": "Dearth RK, Cui X, Kim HJ, Hadsell DL, Lee AV: Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle. 2007, 6: 705-713. 10.4161/cc.6.6.4035.", "journal-title": "Cell Cycle"}, {"key": "2750_CR22", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1007/BF00666187", "volume": "29", "author": "RI Nicholson", "year": "1994", "unstructured": "Nicholson RI, McClelland RA, Gee JMW, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW: Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy. Breast Cancer Res Treat. 1994, 29: 117-125. 10.1007/BF00666187.", "journal-title": "Breast Cancer Res Treat"}, {"key": "2750_CR23", "doi-asserted-by": "publisher", "first-page": "1032", "DOI": "10.1210/en.2002-220620", "volume": "144", "author": "JM Knowlden", "year": "2003", "unstructured": "Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI: Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology. 2003, 144: 1032-1044. 10.1210/en.2002-220620.", "journal-title": "Endocrinology"}, {"key": "2750_CR24", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.1023/B:CLIN.0000037697.76011.1d", "volume": "21", "author": "S Hiscox", "year": "2004", "unstructured": "Hiscox S, Morgan L, Barrow D, Dutkowskil C, Wakeling A, Nicholson RI: Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib ('Iressa', ZD1839). Clin Exp Metastasis. 2004, 21: 201-212.", "journal-title": "Clin Exp Metastasis"}, {"issue": "Suppl 1", "key": "2750_CR25", "doi-asserted-by": "publisher", "first-page": "S29", "DOI": "10.1677/erc.1.00991", "volume": "12", "author": "RI Nicholson", "year": "2005", "unstructured": "Nicholson RI, Hutcheson IR, Hiscox SE, Knowlden JM, Giles M, Barrow D, Gee JM: Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer. Endocr Relat Cancer. 2005, 12 (Suppl 1): S29-S36.", "journal-title": "Endocr Relat Cancer"}, {"key": "2750_CR26", "doi-asserted-by": "publisher", "first-page": "4158", "DOI": "10.1046/j.1432-1327.2001.02327.x", "volume": "268", "author": "T Fujioka", "year": "2001", "unstructured": "Fujioka T, Kim JH, Adachi H, Saito K, Tsujimoto M, Yokoyama S, Ui M: Further evidence for the involvement of insulin receptor substrates in epidermal growth factor-induced activation of phosphatidylinositol 3-kinase. Eur J Biochem. 2001, 268: 4158-4168. 10.1046/j.1432-1327.2001.02327.x.", "journal-title": "Eur J Biochem"}, {"key": "2750_CR27", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1046/j.1432-1327.2001.01831.x", "volume": "268", "author": "T Fujioka", "year": "2001", "unstructured": "Fujioka T, Ui M: Involvement of insulin receptor substrates in epidermal growth factor induced activation of phosphatidylinositol 3-kinase in rat hepatocyte primary culture. Eur J Biochem. 2001, 268: 25-34. 10.1046/j.1432-1327.2001.01831.x.", "journal-title": "Eur J Biochem"}, {"key": "2750_CR28", "doi-asserted-by": "publisher", "first-page": "168", "DOI": "10.1038/nature04177", "volume": "439", "author": "RB Jones", "year": "2006", "unstructured": "Jones RB, Gordus A, Krall JA, MacBeath G: A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006, 439: 168-174. 10.1038/nature04177.", "journal-title": "Nature"}, {"key": "2750_CR29", "doi-asserted-by": "publisher", "first-page": "79", "DOI": "10.1007/s10549-007-9763-9", "volume": "111", "author": "JM Knowlden", "year": "2007", "unstructured": "Knowlden JM, Jones HE, Barrow D, Gee JM, Nicholson RI, Hutcheson IR: Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for gefitinib ('Iressa') response and resistance. Breast Cancer Res Treat. 2007, 111: 79-91.", "journal-title": "Breast Cancer Res Treat"}, {"key": "2750_CR30", "doi-asserted-by": "publisher", "first-page": "R50", "DOI": "10.1186/bcr1754", "volume": "9", "author": "IR Hutcheson", "year": "2007", "unstructured": "Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JM, Robertson JF, Ellis IO, Nicholson RI: Heregulin \u03b21 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells. Breast Cancer Res. 2007, 9: R50-10.1186/bcr1754.", "journal-title": "Breast Cancer Res"}, {"key": "2750_CR31", "doi-asserted-by": "crossref", "first-page": "2831", "DOI": "10.1002/j.1460-2075.1994.tb06577.x", "volume": "13", "author": "SA Prigent", "year": "1994", "unstructured": "Prigent SA, Gullick WJ: Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 1994, 13: 2831-2841.", "journal-title": "EMBO J"}, {"key": "2750_CR32", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1038/nrc2656", "volume": "9", "author": "J Baselga", "year": "2009", "unstructured": "Baselga J, Swain SM: Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat Rev Cancer. 2009, 9: 463-475. 10.1038/nrc2656.", "journal-title": "Nat Rev Cancer"}, {"key": "2750_CR33", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1007/s10911-008-9077-5", "volume": "13", "author": "AW Hamburger", "year": "2008", "unstructured": "Hamburger AW: The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies. J Mammary Gland Biol Neoplasia. 2008, 13: 225-233. 10.1007/s10911-008-9077-5.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "2750_CR34", "doi-asserted-by": "publisher", "first-page": "1116", "DOI": "10.1038/bjc.1992.420", "volume": "66", "author": "NR Lemoine", "year": "1992", "unstructured": "Lemoine NR, Barnes DM, Hollywood DP, Hughes CM, Smith P, Dublin E, Prigent SA, Gullick WJ, Hurst HC: Expression of the ERBB3 gene product in breast cancer. Br J Cancer. 1992, 66: 1116-1121. 10.1038/bjc.1992.420.", "journal-title": "Br J Cancer"}, {"key": "2750_CR35", "doi-asserted-by": "publisher", "first-page": "1385", "DOI": "10.1038/bjc.1998.689", "volume": "78", "author": "R Naidu", "year": "1998", "unstructured": "Naidu R, Yadav M, Nair S, Kutty MK: Expression of c-erbB3 protein in primary breast carcinomas. Br J Cancer. 1998, 78: 1385-1390. 10.1038/bjc.1998.689.", "journal-title": "Br J Cancer"}, {"key": "2750_CR36", "doi-asserted-by": "publisher", "first-page": "229", "DOI": "10.1038/bjc.1996.342", "volume": "74", "author": "A Travis", "year": "1996", "unstructured": "Travis A, Pinder SE, Robertson JF, Bell JA, Wencyk P, Gullick WJ, Nicholson RI, Poller DN, Blamey RW, Elston CW, Ellis IO: C-erbB3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. Cancer. 1996, 74: 229-233. 10.1038/bjc.1996.342.", "journal-title": "Cancer"}, {"key": "2750_CR37", "doi-asserted-by": "crossref", "first-page": "2452", "DOI": "10.1002/j.1460-2075.1996.tb00603.x", "volume": "15", "author": "R Pinkas-Kramarski", "year": "1996", "unstructured": "Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y: Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J. 1996, 15: 2452-2467.", "journal-title": "EMBO J"}, {"key": "2750_CR38", "doi-asserted-by": "publisher", "first-page": "1770", "DOI": "10.1002/cncr.20970", "volume": "103", "author": "SM Wiseman", "year": "2005", "unstructured": "Wiseman SM, Makretsov N, Nielsen TO, Gilks B, Yorida E, Cheang M, Turbin D, Gelmon K, Huntsman DG: Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival. Cancer. 2005, 103: 1770-1777. 10.1002/cncr.20970.", "journal-title": "Cancer"}, {"key": "2750_CR39", "doi-asserted-by": "publisher", "first-page": "5445", "DOI": "10.1158/1078-0432.CCR-08-2980", "volume": "15", "author": "C Desbois-Mouthon", "year": "2009", "unstructured": "Desbois-Mouthon C, Baron A, Blivet-Van Eggelpo\u00ebl MJ, Fartoux L, Venot C, Bladt F, Housset C, Rosmorduc O: Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma. Clin Cancer Res. 2009, 15: 5445-5456. 10.1158/1078-0432.CCR-08-2980.", "journal-title": "Clin Cancer Res"}, {"key": "2750_CR40", "doi-asserted-by": "publisher", "first-page": "172", "DOI": "10.1038/sj.bjc.6603237", "volume": "95", "author": "HE Jones", "year": "2006", "unstructured": "Jones HE, Gee JMW, Barrow D, Tonge D, Holloway B, Nicholson RI: Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. Br J Cancer. 2006, 95: 172-180. 10.1038/sj.bjc.6603237.", "journal-title": "Br J Cancer"}, {"key": "2750_CR41", "doi-asserted-by": "publisher", "first-page": "1949", "DOI": "10.1038/sj.onc.1202107", "volume": "17", "author": "JM Knowlden", "year": "1998", "unstructured": "Knowlden JM, Gee JM, Seery LT, Farrow L, Gullick WJ, Ellis IO, Blamey RW, Robertson JF, Nicholson R: c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene. 1998, 17: 1949-1957. 10.1038/sj.onc.1202107.", "journal-title": "Oncogene"}, {"key": "2750_CR42", "doi-asserted-by": "publisher", "first-page": "1220", "DOI": "10.1038/sj.bjc.6603354", "volume": "95", "author": "SA Byron", "year": "2006", "unstructured": "Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X, Yee D: Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer. 2006, 95: 1220-1228. 10.1038/sj.bjc.6603354.", "journal-title": "Br J Cancer"}, {"key": "2750_CR43", "doi-asserted-by": "publisher", "first-page": "14", "DOI": "10.1016/j.canlet.2009.02.056", "volume": "282", "author": "T Mukohara", "year": "2009", "unstructured": "Mukohara T, Shimada H, Ogasawara N, Wanikawa R, Shimomura M, Nakatsura T, Ishii G, Park JO, J\u00e4nne PA, Saijo N, Minami H: Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-IR) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression. Cancer Lett. 2009, 282: 14-24. 10.1016/j.canlet.2009.02.056.", "journal-title": "Cancer Lett"}, {"key": "2750_CR44", "doi-asserted-by": "publisher", "first-page": "9994", "DOI": "10.1074/jbc.273.16.9994", "volume": "273", "author": "JG Jackson", "year": "1998", "unstructured": "Jackson JG, White MF, Yee D: Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J Biol Chem. 1998, 273: 9994-10003. 10.1074/jbc.273.16.9994.", "journal-title": "J Biol Chem"}, {"key": "2750_CR45", "first-page": "1813", "volume": "10", "author": "M Alimandi", "year": "1995", "unstructured": "Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH: Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene. 1995, 10: 1813-1821.", "journal-title": "Oncogene"}, {"key": "2750_CR46", "doi-asserted-by": "publisher", "first-page": "1538", "DOI": "10.1158/0008-5472.CAN-07-5935", "volume": "68", "author": "AK Chakraborty", "year": "2008", "unstructured": "Chakraborty AK, Liang K, DiGiovanna MP: Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer. Cancer Res. 2008, 68: 1538-1545. 10.1158/0008-5472.CAN-07-5935.", "journal-title": "Cancer Res"}, {"key": "2750_CR47", "doi-asserted-by": "publisher", "first-page": "2589", "DOI": "10.1158/1535-7163.MCT-08-0493", "volume": "7", "author": "P Haluska", "year": "2008", "unstructured": "Haluska P, Carboni JM, Ten Eyck C, Attar RM, Hou X, Yu C, Sagar M, Wong TW, Gottardis MM, Erlichman CM: HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924. Mol Cancer Ther. 2008, 7: 2589-2598. 10.1158/1535-7163.MCT-08-0493.", "journal-title": "Mol Cancer Ther"}, {"key": "2750_CR48", "doi-asserted-by": "publisher", "first-page": "e1000563", "DOI": "10.1371/journal.pbio.1000563", "volume": "8", "author": "M Gijsen", "year": "2010", "unstructured": "Gijsen M, King P, Perera T, Parker PJ, Harris AL, Larijani B, Kong A: HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol. 2010, 8: e1000563-10.1371/journal.pbio.1000563.", "journal-title": "PLoS Biol"}, {"key": "2750_CR49", "doi-asserted-by": "publisher", "first-page": "672", "DOI": "10.1002/path.1561", "volume": "203", "author": "M Dunn", "year": "2004", "unstructured": "Dunn M, Sinha P, Campbell R, Blackburn E, Levinson N, Rampaul R, Bates T, Humphreys S, Gullick WJ: Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancer. J Pathol. 2004, 203: 672-680. 10.1002/path.1561.", "journal-title": "J Pathol"}, {"key": "2750_CR50", "doi-asserted-by": "publisher", "first-page": "727", "DOI": "10.1016/j.yexcr.2008.09.017", "volume": "315", "author": "R Baserga", "year": "2009", "unstructured": "Baserga R: The insulin receptor substrate-1: a biomarker for cancer?. Exp Cell Res. 2009, 315: 727-732. 10.1016/j.yexcr.2008.09.017.", "journal-title": "Exp Cell Res"}, {"key": "2750_CR51", "doi-asserted-by": "publisher", "first-page": "R56", "DOI": "10.1186/bcr2113", "volume": "10", "author": "J Lisztwan", "year": "2008", "unstructured": "Lisztwan J, Pornon A, Chen B, Chen S, Evans DB: The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer. Breast Cancer Res. 2008, 10: R56-10.1186/bcr2113.", "journal-title": "Breast Cancer Res"}, {"key": "2750_CR52", "doi-asserted-by": "publisher", "first-page": "836", "DOI": "10.1055/s-2004-814145", "volume": "35", "author": "JJ Ye", "year": "2003", "unstructured": "Ye JJ, Liang SJ, Guo N, Li SL, Wu AM, Giannini S, Sachdev D, Yee D, Br\u00fcnner N, Ikle D, Fujita-Yamaguchi Y: Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo. Horm Metab Res. 2003, 35: 836-842.", "journal-title": "Horm Metab Res"}], "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr3018.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr3018/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr3018.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 16]], "date-time": "2019-06-16T06:13:43Z", "timestamp": 1560665623000}, "score": 47.180332, "issued": {"date-parts": [[2011, 9, 22]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2011, 10]]}, "issue": "5"}, "alternative-id": ["2750"], "URL": "http://dx.doi.org/10.1186/bcr3018", "relation": {"cites": []}, "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "article-number": "R93"}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:30:24Z", "timestamp": 1574094624264}, "reference-count": 25, "publisher": "Elsevier BV", "issue": "1-2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1996, 12, 1]], "date-time": "1996-12-01T00:00:00Z", "timestamp": 849398400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Letters"], "published-print": {"date-parts": [[1996, 12]]}, "DOI": "10.1016/s0304-3835(96)04462-x", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T12:00:58Z", "timestamp": 1027598458000}, "page": "223-230", "source": "Crossref", "is-referenced-by-count": 17, "title": ["The 12-lipoxygenase gene-transfected MCF-7 human breast cancer cell line exhibits estrogen-independent, but estrogen and omega-6 fatty acid-stimulated proliferation in vitro, and enhanced growth in athymic nude mice"], "prefix": "10.1016", "volume": "109", "author": [{"given": "Xin-Hua", "family": "Liu", "sequence": "first", "affiliation": []}, {"given": "Jeanne M.", "family": "Connolly", "sequence": "additional", "affiliation": []}, {"given": "David P.", "family": "Rose", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Letters"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S030438359604462X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S030438359604462X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 1]], "date-time": "2019-05-01T05:23:16Z", "timestamp": 1556688196000}, "score": 46.946465, "issued": {"date-parts": [[1996, 12]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[1996, 12]]}, "issue": "1-2"}, "alternative-id": ["S030438359604462X"], "URL": "http://dx.doi.org/10.1016/s0304-3835(96)04462-x", "ISSN": ["0304-3835"], "issn-type": [{"value": "0304-3835", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:55:33Z", "timestamp": 1574322933599}, "reference-count": 41, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 9, 28]], "date-time": "2007-09-28T00:00:00Z", "timestamp": 1190937600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2008, 9]]}, "DOI": "10.1007/s10549-007-9763-9", "type": "journal-article", "created": {"date-parts": [[2007, 9, 27]], "date-time": "2007-09-27T16:41:42Z", "timestamp": 1190911302000}, "page": "79-91", "source": "Crossref", "is-referenced-by-count": 51, "title": ["Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (\u2018Iressa\u2019) response and resistance"], "prefix": "10.1007", "volume": "111", "author": [{"given": "Janice M.", "family": "Knowlden", "sequence": "first", "affiliation": []}, {"given": "Helen E.", "family": "Jones", "sequence": "additional", "affiliation": []}, {"given": "Denise", "family": "Barrow", "sequence": "additional", "affiliation": []}, {"given": "Julia M. W.", "family": "Gee", "sequence": "additional", "affiliation": []}, {"given": "Robert I.", "family": "Nicholson", "sequence": "additional", "affiliation": []}, {"given": "Iain R.", "family": "Hutcheson", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 9, 28]]}, "reference": [{"key": "9763_CR1", "doi-asserted-by": "crossref", "first-page": "3159", "DOI": "10.1093/emboj/19.13.3159", "volume": "19", "author": "MA Olayioye", "year": "2000", "unstructured": "Olayioye MA, Neve RM, Lane HA, Hynes N (2000) The erbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19:3159\u20133167", "journal-title": "EMBO J"}, {"issue": "Suppl 4", "key": "9763_CR2", "doi-asserted-by": "crossref", "first-page": "S9", "DOI": "10.1016/S0959-8049(01)00231-3", "volume": "37", "author": "RI Nicholson", "year": "2001", "unstructured": "Nicholson RI, Gee JMW, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37(Suppl 4):S9\u2013S15", "journal-title": "Eur J Cancer"}, {"key": "9763_CR3", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1016/1040-8428(94)00144-I", "volume": "19", "author": "DS Salomon", "year": "1995", "unstructured": "Salomon DS, Bradt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183\u2013232", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "9763_CR4", "unstructured": "Schlessinger J (2000) Cell Signaling by receptor tyrosine kinases cell 103:211\u2013225", "DOI": "10.1016/S0092-8674(00)00114-8", "doi-asserted-by": "crossref"}, {"key": "9763_CR5", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1634/theoncologist.7-suppl_4-2", "volume": "7", "author": "J Baselga", "year": "2002", "unstructured": "Baselga J (2002) Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist 7:2\u20138", "journal-title": "Oncologist"}, {"key": "9763_CR6", "doi-asserted-by": "crossref", "first-page": "2445", "DOI": "10.1200/JCO.2005.11.890", "volume": "23", "author": "J Baselga", "year": "2005", "unstructured": "Baselga J, Arteaga CL (2005) Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 23:2445\u20132459", "journal-title": "J Clin Oncol"}, {"issue": "Suppl 1", "key": "9763_CR7", "doi-asserted-by": "crossref", "first-page": "S135", "DOI": "10.1677/erc.1.01059", "volume": "12", "author": "A Agrawal", "year": "2005", "unstructured": "Agrawal A, Gutteridge E, Gee JM, Nicholson RI, Robertson JF (2005) Overview of tyrosine kinase inhibitors in clinical breast cancer. Endocr Relat Cancer 12(Suppl 1):S135\u2013S144", "journal-title": "Endocr Relat Cancer"}, {"key": "9763_CR8", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1677/erc.1.00992", "volume": "12", "author": "SRD Johnston", "year": "2005", "unstructured": "Johnston SRD (2005) Clinical trials of intracellular signal transductions inhibitors for breast cancer\u2014a strategy to overcome endocrine resistance. Endocr Relat Cancer 12:145\u2013157", "journal-title": "Endocr Relat Cancer"}, {"key": "9763_CR9", "doi-asserted-by": "crossref", "first-page": "2240", "DOI": "10.1200/JCO.2002.10.112", "volume": "20", "author": "M Ranson", "year": "2002", "unstructured": "Ranson M, Hammond LA, Ferry D, Kris M, Tullo A, Murray PI, Miller V, Averbuch S, Ochs J, Morris C, Feyereislova A, Swaisland H, Rowinsky EK (2002) ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial. J Clin Oncol 20:2240\u20132250", "journal-title": "J Clin Oncol"}, {"key": "9763_CR10", "doi-asserted-by": "crossref", "first-page": "1327", "DOI": "10.1093/jnci/85.16.1327", "volume": "18", "author": "J Baselga", "year": "1993", "unstructured": "Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, Mendelsohn J (1993) Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 18:1327\u20131333", "journal-title": "J Natl Cancer Inst"}, {"key": "9763_CR11", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1517/14796694.1.2.221", "volume": "1", "author": "F Ciardiello", "year": "2005", "unstructured": "Ciardiello F (2005) Epidermal growth factor receptor inhibitors in cancer treatment. Future Oncol 1:221\u2013234", "journal-title": "Future Oncol"}, {"key": "9763_CR12", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1053/sonc.2002.31521", "volume": "29", "author": "D Raben", "year": "2002", "unstructured": "Raben D, Helfrich BA, Chan D, Johnson G, Bunn PA Jr (2002) Zd1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol 29:37\u201346", "journal-title": "Semin Oncol"}, {"key": "9763_CR13", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1038/sj.bjc.6601921", "volume": "91", "author": "BF El-Rayes", "year": "2004", "unstructured": "El-Rayes BF, LoRusso PM (2004) Targeting the epidermal growth factor receptor. Br J Cancer 91:418\u2013424", "journal-title": "Br J Cancer"}, {"key": "9763_CR14", "doi-asserted-by": "crossref", "first-page": "2129", "DOI": "10.1056/NEJMoa040938", "volume": "350", "author": "TJ Lynch", "year": "2004", "unstructured": "Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350:2129\u20132139", "journal-title": "N Engl J Med"}, {"key": "9763_CR15", "doi-asserted-by": "crossref", "first-page": "1497", "DOI": "10.1126/science.1099314", "volume": "304", "author": "JG Paez", "year": "2004", "unstructured": "Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304:1497\u20131500", "journal-title": "Science"}, {"key": "9763_CR16", "doi-asserted-by": "crossref", "first-page": "461", "DOI": "10.2217/14796694.1.4.461", "volume": "14", "author": "RF Riedel", "year": "2005", "unstructured": "Riedel RF, Febbo PG (2005) Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer. Future Oncol 14:461\u2013466", "journal-title": "Future Oncol"}, {"key": "9763_CR17", "doi-asserted-by": "crossref", "first-page": "2812", "DOI": "10.1038/sj.onc.1206388", "volume": "22", "author": "R Bianco", "year": "2003", "unstructured": "Bianco R, Shin I, Ritter CA, Yakes FM, Basso A, Rosen N, Tsurutani J, Dennis PA, Mills GB, Arteaga CL (2003) Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors. Oncogene 22:2812\u20132822", "journal-title": "Oncogene"}, {"key": "9763_CR18", "doi-asserted-by": "crossref", "first-page": "1913", "DOI": "10.1038/sj.onc.1204277", "volume": "20", "author": "B Liu", "year": "2001", "unstructured": "Liu B, Fang M, Lu Y, Mendelsohn J, Fan Z (2001) Fibroblast growth factor and insulin-like growth factor differentially modulate the apoptosis and G1 arrest induced by anti-epidermal growth factor receptor monoclonal antibody. Oncogene 20:1913\u20131922", "journal-title": "Oncogene"}, {"key": "9763_CR19", "first-page": "200", "volume": "62", "author": "A Chakravarti", "year": "2002", "unstructured": "Chakravarti A, Loeffler JS, Dyson NJ (2002) Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signalling. Cancer Res 62:200\u2013207", "journal-title": "Cancer Res"}, {"key": "9763_CR20", "doi-asserted-by": "crossref", "first-page": "793", "DOI": "10.1677/erc.1.00799", "volume": "11", "author": "HE Jones", "year": "2004", "unstructured": "Jones HE, Goddard L, Gee JMW, Hiscox S, Rubini M, Barrow D, Knowlden JM, Williams S, Wakeling AE, Nicholson RI (2004) Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocr Relat Cancer 11:793\u2013814", "journal-title": "Endocr Relat Cancer"}, {"key": "9763_CR21", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1186/bcr1028", "volume": "7", "author": "A Camirand", "year": "2005", "unstructured": "Camirand A, Zakikhani M, Young F, Pollak M (2005) Inhibition of insulin-like growth factor receptor signalling enhances growth-inhibitory and pro-apoptotic effects of gefitinib (Iressa) in human breast cancer cells. Breast Cancer Res 7:570\u2013579", "journal-title": "Breast Cancer Res"}, {"key": "9763_CR22", "doi-asserted-by": "crossref", "first-page": "2503", "DOI": "10.1002/j.1460-2075.1986.tb04528.x", "volume": "5", "author": "A Ullrich", "year": "1986", "unstructured": "Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y (1986) Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503\u20132512", "journal-title": "EMBO J"}, {"key": "9763_CR23", "first-page": "103", "volume": "3", "author": "RL Rocha", "year": "1997", "unstructured": "Rocha RL, Hilsenbeck SG, Jackson JG, Van Den Berg CL, Weng C, Lee AV, Yee D (1997) Insulin-like growth factor binding protein 3 and insulin receptor substrate 1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Can Res 3:103\u2013109", "journal-title": "Clin Can Res"}, {"key": "9763_CR24", "first-page": "3079", "volume": "57", "author": "BC Turner", "year": "1997", "unstructured": "Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L, Burgaud JL, Carter D, Baserga R, Glazer PM (1997) IGF-I receptor and cyclin D1 expression influence cellular radiosensitivity and local recurrence after lumpectomy and radiation. Cancer Res 57:3079\u20133083", "journal-title": "Cancer Res"}, {"key": "9763_CR25", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1007/s001250051387", "volume": "40", "author": "MF White", "year": "1997", "unstructured": "White MF (1997) The insulin signalling system and the IRS proteins. Diabetologia 40:2\u201317", "journal-title": "Diabetologia"}, {"key": "9763_CR26", "doi-asserted-by": "crossref", "first-page": "2833", "DOI": "10.1210/endo.142.7.8283", "volume": "142", "author": "DL Esposito", "year": "2001", "unstructured": "Esposito DL, Li Y, Cama A, Quon MJ (2001) Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142:2833\u20132840", "journal-title": "Endocrinology"}, {"key": "9763_CR27", "doi-asserted-by": "crossref", "first-page": "875", "DOI": "10.1042/bj20020903", "volume": "368", "author": "I Hers", "year": "2002", "unstructured": "Hers I, Bell CJ, Poole AW, Jiang D, Denton RM, Schaeffer E, Tavare JM (2002) Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes. Biochem J 368:875\u2013884", "journal-title": "Biochem J"}, {"key": "9763_CR28", "doi-asserted-by": "crossref", "first-page": "1852", "DOI": "10.1093/jnci/93.24.1852", "volume": "93", "author": "Y Lu", "year": "2001", "unstructured": "Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M (2001) Insulin-like growth factor receptor signalling and resistance to trastuzumab (Herceptin). J Natl Cancer Inst 93:1852\u20131857", "journal-title": "J Natl Cancer Inst"}, {"key": "9763_CR29", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1002/ijc.11445", "volume": "108", "author": "Y Lu", "year": "2004", "unstructured": "Lu Y, Xiaolin ZI, Pollak M (2004) Molecular mechanisms underlying IGF-I-induced attenuation of the growth inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells. Int J Cancer 108:334\u2013341", "journal-title": "Int J Cancer"}, {"key": "9763_CR30", "doi-asserted-by": "crossref", "first-page": "1032", "DOI": "10.1210/en.2002-220620", "volume": "144", "author": "JM Knowlden", "year": "2003", "unstructured": "Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI (2003) Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology 144:1032\u20131044", "journal-title": "Endocrinology"}, {"key": "9763_CR31", "doi-asserted-by": "crossref", "first-page": "172", "DOI": "10.1038/sj.bjc.6603237", "volume": "95", "author": "HE Jones", "year": "2006", "unstructured": "Jones HE, Gee JM, Barrow D, Tonge D, Holloway B, Nicholson RI (2006) Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. Br J Cancer 95:172\u2013180", "journal-title": "Br J Cancer"}, {"key": "9763_CR32", "doi-asserted-by": "crossref", "first-page": "4609", "DOI": "10.1210/en.2005-0247", "volume": "146", "author": "JM Knowlden", "year": "2005", "unstructured": "Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI (2005) Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor. Endocrinology 146:4609\u20134618", "journal-title": "Endocrinology"}, {"key": "9763_CR33", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1023/B:BREA.0000041623.21338.47", "volume": "87", "author": "NJ Jordan", "year": "2004", "unstructured": "Jordan NJ, Gee JMW, Barrow D, Wakeling AE, Nicholson RI (2004) Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells. Breast Cancer Res Treat 87:167\u2013180", "journal-title": "Breast Cancer Res Treat"}, {"key": "9763_CR34", "doi-asserted-by": "crossref", "first-page": "4158", "DOI": "10.1046/j.1432-1327.2001.02327.x", "volume": "268", "author": "T Fujioka", "year": "2001", "unstructured": "Fujioka T, Kim JH, Adachi H, Saito K, Tsujimoto M, Yokoyama S, Ui M (2001) Further evidence for the involvement of insulin receptor substrates in epidermal growth factor-induced activation of phosphatidylinositol 3-kinase. Eur J Biochem 268:4158\u20134168", "journal-title": "Eur J Biochem"}, {"key": "9763_CR35", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1046/j.1432-1327.2001.01831.x", "volume": "268", "author": "T Fujioka", "year": "2001", "unstructured": "Fujioka T, Ui M (2001) Involvement of insulin receptor substrates in epidermal growth factor induced activation of phosphatidylinositol 3-kinase in rat hepatocyte primary culture. Eur J Biochem 268:25\u201334", "journal-title": "Eur J Biochem"}, {"key": "9763_CR36", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1210/endo.136.2.7835273", "volume": "136", "author": "RW Hardy", "year": "1995", "unstructured": "Hardy RW, Gupta KB, McDonald JM, Williford J, Wells A (1995) Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes. Endocrinology 136:431\u2013439", "journal-title": "Endocrinology"}, {"key": "9763_CR37", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1038/nature04177", "volume": "439", "author": "RB Jones", "year": "2006", "unstructured": "Jones RB, Gordus A, Krall JA, MacBeath G (2006) A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 439:168\u2013174", "journal-title": "Nature"}, {"key": "9763_CR38", "doi-asserted-by": "crossref", "first-page": "14863", "DOI": "10.1074/jbc.270.25.14863", "volume": "270", "author": "Z Songyang", "year": "1995", "unstructured": "Songyang Z, Margolis B, Chaudhuri M, Shoelson SE, Cantley LC (1995) The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J Biol Chem 270:14863\u201314866", "journal-title": "J Biol Chem"}, {"key": "9763_CR39", "doi-asserted-by": "crossref", "first-page": "22558", "DOI": "10.1074/jbc.M000412200", "volume": "275", "author": "H Zhang", "year": "2000", "unstructured": "Zhang H, Hoff H, Sell C (2000) Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells. J Biol Chem 275:22558\u201322562", "journal-title": "J Biol Chem"}, {"key": "9763_CR40", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1158/1078-0432.CCR-031206", "volume": "10", "author": "RI Nicholson", "year": "2004", "unstructured": "Nicholson RI, Hutcheson IR, Knowlden JM, Jones H, Harper ME, Jordan N, Hiscox SE, Barrow B, Gee JMW (2004) Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors. Clin Cancer Res 10:346\u2013354", "journal-title": "Clin Cancer Res"}, {"key": "9763_CR41", "doi-asserted-by": "crossref", "first-page": "2687", "DOI": "10.1038/sj.onc.1203587", "volume": "19", "author": "K Reiss", "year": "2000", "unstructured": "Reiss K, Wang JY, Romano G, Furnari FB, Cavenee WK, Morrione A, Tu X, Baserga R (2000) IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation. Oncogene 19:2687\u20132694", "journal-title": "Oncogene"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10549-007-9763-9.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10549-007-9763-9/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10549-007-9763-9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T16:28:54Z", "timestamp": 1559233734000}, "score": 46.70481, "issued": {"date-parts": [[2007, 9, 28]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2008, 9]]}, "issue": "1"}, "alternative-id": ["9763"], "URL": "http://dx.doi.org/10.1007/s10549-007-9763-9", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T07:32:27Z", "timestamp": 1574839947599}, "reference-count": 50, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2017, 10, 2]], "date-time": "2017-10-02T00:00:00Z", "timestamp": 1506902400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["npj Breast Cancer"], "published-print": {"date-parts": [[2017, 12]]}, "DOI": "10.1038/s41523-017-0041-7", "type": "journal-article", "created": {"date-parts": [[2017, 9, 26]], "date-time": "2017-09-26T16:09:00Z", "timestamp": 1506442140000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue"], "prefix": "10.1038", "volume": "3", "author": [{"given": "Hannah", "family": "Oh", "sequence": "first", "affiliation": []}, {"given": "A. Heather", "family": "Eliassen", "sequence": "additional", "affiliation": []}, {"given": "Andrew H.", "family": "Beck", "sequence": "additional", "affiliation": []}, {"given": "Bernard", "family": "Rosner", "sequence": "additional", "affiliation": []}, {"given": "Stuart J.", "family": "Schnitt", "sequence": "additional", "affiliation": []}, {"given": "Laura C.", "family": "Collins", "sequence": "additional", "affiliation": []}, {"given": "James L.", "family": "Connolly", "sequence": "additional", "affiliation": []}, {"given": "Laleh", "family": "Montaser-Kouhsari", "sequence": "additional", "affiliation": []}, {"given": "Walter C.", "family": "Willett", "sequence": "additional", "affiliation": []}, {"given": "Rulla M.", "family": "Tamimi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 10, 2]]}, "reference": [{"key": "41_CR1", "unstructured": "Ferlay, J. et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11, \n                        http://globocan.iarc.fr\n                        \n                     (2014)."}, {"key": "41_CR2", "unstructured": "American Cancer Society. Breast Cancer Facts & Figures, 2015\u20132016. (2015)."}, {"key": "41_CR3", "unstructured": "Howlader, N. et al. SEER Cancer Statistics Review, 1975\u20132014,\u00a0National Cancer Institute. Bethesda, MD,\u00a0\n                        https://seer.cancer.gov/csr/1975_2014/\n                        \n                     (2017)."}, {"key": "41_CR4", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1093/oxfordjournals.epirev.a036115", "volume": "15", "author": "JL Kelsey", "year": "1993", "unstructured": "Kelsey, J. L., Gammon, M. D. & John, E. M. Reproductive factors and breast cancer. Epidemiol. Rev. 15, 36\u201347 (1993).", "journal-title": "Epidemiol. Rev."}, {"key": "41_CR5", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1038/303767a0", "volume": "303", "author": "MC Pike", "year": "1983", "unstructured": "Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T. & Hoel, D. G. \u2018Hormonal\u2019 risk factors, \u2018breast tissue age\u2019 and the age-incidence of breast cancer. Nature 303, 767\u2013770 (1983).", "journal-title": "Nature"}, {"key": "41_CR6", "doi-asserted-by": "crossref", "first-page": "1713", "DOI": "10.1016/S0140-6736(96)90806-5", "volume": "347", "author": "Collaborative Group on Hormonal Factors in Breast Cancer.", "year": "1996", "unstructured": "Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 347, 1713\u20131727 (1996).", "journal-title": "Lancet"}, {"key": "41_CR7", "doi-asserted-by": "crossref", "first-page": "1047", "DOI": "10.1016/S0140-6736(97)08233-0", "volume": "350", "author": "Collaborative Group on Hormonal Factors in Breast Cancer.", "year": "1997", "unstructured": "Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 350, 1047\u20131059 (1997).", "journal-title": "Lancet"}, {"key": "41_CR8", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1093/aje/152.6.514", "volume": "152", "author": "PA Brandt van den", "year": "2000", "unstructured": "van den Brandt, P. A. et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am. J. Epidemiol. 152, 514\u2013527 (2000).", "journal-title": "Am. J. Epidemiol."}, {"key": "41_CR9", "doi-asserted-by": "crossref", "first-page": "1389", "DOI": "10.1016/S0140-6736(01)06524-2", "volume": "358", "author": "Collaborative Group on Hormonal Factors in Breast Cancer.", "year": "2001", "unstructured": "Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358, 1389\u20131399 (2001).", "journal-title": "Lancet"}, {"key": "41_CR10", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1007/s10552-006-0011-0", "volume": "17", "author": "J Key", "year": "2006", "unstructured": "Key, J. et al. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17, 759\u2013770 (2006).", "journal-title": "Cancer Causes Control"}, {"key": "41_CR11", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1007/s10549-012-2396-7", "volume": "137", "author": "Y Wu", "year": "2013", "unstructured": "Wu, Y., Zhang, D. & Kang, S. Physical activity and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res. Treat. 137, 869\u2013882 (2013).", "journal-title": "Breast Cancer Res. Treat."}, {"key": "41_CR12", "author": "Z Cheraghi", "volume": "7", "year": "2012", "unstructured": "Cheraghi, Z., Poorolajal, J., Hashem, T., Esmailnasab, N. & Doosti Irani, A. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS ONE 7, e51446 (2012).", "journal-title": "PLoS ONE", "DOI": "10.1371/journal.pone.0051446", "doi-asserted-by": "crossref"}, {"key": "41_CR13", "doi-asserted-by": "crossref", "first-page": "606", "DOI": "10.1093/jnci/94.8.606", "volume": "94", "author": "T Key", "year": "2002", "unstructured": "Key, T., Appleby, P., Barnes, I. & Reeves, G. & Endogenous Hormones and Breast Cancer Collaborative Group Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl Cancer Inst. 94, 606\u2013616 (2002).", "journal-title": "J. Natl Cancer Inst."}, {"key": "41_CR14", "doi-asserted-by": "crossref", "first-page": "1009", "DOI": "10.1016/S1470-2045(13)70301-2", "volume": "14", "author": "Endogenous Hormones and Breast Cancer Collaborative Group.", "year": "2013", "unstructured": "Endogenous Hormones and Breast Cancer Collaborative Group. et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 14, 1009\u20131019 (2013).", "journal-title": "Lancet Oncol."}, {"key": "41_CR15", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1016/S1470-2045(10)70095-4", "volume": "11", "author": "TJ Key", "year": "2010", "unstructured": "Endogenous Hormones and Breast Cancer Collaborative Group, Key, T. J., Appleby, P. N., Reeves, G. K. & Roddam, A. W. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 11, 530\u2013542 (2010).", "journal-title": "Lancet Oncol."}, {"key": "41_CR16", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1186/bcr452", "volume": "4", "author": "E Anderson", "year": "2002", "unstructured": "Anderson, E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 4, 197\u2013201 (2002).", "journal-title": "Breast Cancer Res."}, {"key": "41_CR17", "first-page": "311", "volume": "73", "author": "R Rubin", "year": "1995", "unstructured": "Rubin, R. & Baserga, R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 73, 311\u2013331 (1995).", "journal-title": "Lab. Invest."}, {"key": "41_CR18", "first-page": "2999", "volume": "49", "author": "JH Dierendonck van", "year": "1989", "unstructured": "van Dierendonck, J. H., Keijzer, R., van de Velde, C. J. & Cornelisse, C. J. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res. 49, 2999\u20133006 (1989).", "journal-title": "Cancer Res."}, {"key": "41_CR19", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1007/s10549-009-0534-7", "volume": "121", "author": "M Santisteban", "year": "2010", "unstructured": "Santisteban, M. et al. Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res. Treat. 121, 431\u2013437 (2010).", "journal-title": "Breast Cancer Res. Treat."}, {"key": "41_CR20", "first-page": "993", "volume": "54", "author": "SA Khan", "year": "1994", "unstructured": "Khan, S. A., Rogers, M. A., Obando, J. A. & Tamsen, A. Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res. 54, 993\u2013997 (1994).", "journal-title": "Cancer Res."}, {"key": "41_CR21", "first-page": "4276", "volume": "59", "author": "JP Lydon", "year": "1999", "unstructured": "Lydon, J. P., Ge, G., Kittrell, F. S., Medina, D. & O\u2019Malley, B. W. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 59, 4276\u20134284 (1999).", "journal-title": "Cancer Res."}, {"key": "41_CR22", "doi-asserted-by": "crossref", "first-page": "1926", "DOI": "10.1158/0008-5472.CAN-15-1927", "volume": "76", "author": "SJ Huh", "year": "2016", "unstructured": "Huh, S. J. et al. The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women. Cancer Res. 76, 1926\u20131934 (2016).", "journal-title": "Cancer Res."}, {"key": "41_CR23", "unstructured": "Oh, H. et al. Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer. NPJ Breast Cancer 2, \n                        https://doi.org/10.1038/npjbcancer.2016.32\n                        \n                     (2016).", "DOI": "10.1038/npjbcancer.2016.32", "doi-asserted-by": "publisher"}, {"key": "41_CR24", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1007/s10549-010-1313-1", "volume": "128", "author": "RM Tamimi", "year": "2011", "unstructured": "Tamimi, R. M. et al. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res. Treat. 128, 243\u2013250 (2011).", "journal-title": "Breast Cancer Res. Treat."}, {"key": "41_CR25", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1002/ijc.2910480209", "volume": "48", "author": "G Williams", "year": "1991", "unstructured": "Williams, G. et al. Oral contraceptive (OCP) use increases proliferation and decreases oestrogen receptor content of epithelial cells in the normal human breast. Int. J. Cancer 48, 206\u2013210 (1991).", "journal-title": "Int. J. Cancer"}, {"key": "41_CR26", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1007/BF01810783", "volume": "15", "author": "JD Jacquemier", "year": "1990", "unstructured": "Jacquemier, J. D., Hassoun, J., Torrente, M. & Martin, P. M. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases. Breast Cancer Res. Treat. 15, 109\u2013117 (1990).", "journal-title": "Breast Cancer Res. Treat."}, {"key": "41_CR27", "doi-asserted-by": "crossref", "first-page": "37", "DOI": "10.1093/jnci/90.1.37", "volume": "90", "author": "SA Khan", "year": "1998", "unstructured": "Khan, S. A., Rogers, M. A., Khurana, K. K., Meguid, M. M. & Numann, P. J. Estrogen receptor expression in benign breast epithelium and breast cancer risk. J. Natl Cancer Inst. 90, 37\u201342 (1998).", "journal-title": "J. Natl Cancer Inst."}, {"key": "41_CR28", "doi-asserted-by": "crossref", "first-page": "334", "DOI": "10.1002/ijc.10737", "volume": "102", "author": "SA Khan", "year": "2002", "unstructured": "Khan, S. A., Yee, K. A., Kaplan, C. & Siddiqui, J. F. Estrogen receptor alpha expression in normal human breast epithelium is consistent over time. Int. J. Cancer 102, 334\u2013337 (2002).", "journal-title": "Int. J. Cancer"}, {"key": "41_CR29", "first-page": "5748", "volume": "47", "author": "OW Petersen", "year": "1987", "unstructured": "Petersen, O. W., Hoyer, P. E. & van Deurs, B. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. Cancer Res. 47, 5748\u20135751 (1987).", "journal-title": "Cancer Res."}, {"key": "41_CR30", "doi-asserted-by": "crossref", "first-page": "1811", "DOI": "10.1016/S0002-9440(10)65498-3", "volume": "155", "author": "BS Shoker", "year": "1999", "unstructured": "Shoker, B. S. et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am. J. Pathol. 155, 1811\u20131815 (1999).", "journal-title": "Am. J. Pathol."}, {"key": "41_CR31", "doi-asserted-by": "crossref", "first-page": "601", "DOI": "10.1038/bjc.1992.122", "volume": "65", "author": "S Battersby", "year": "1992", "unstructured": "Battersby, S., Robertson, B. J., Anderson, T. J., King, R. J. & McPherson, K. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br. J. Cancer 65, 601\u2013607 (1992).", "journal-title": "Br. J. Cancer"}, {"key": "41_CR32", "first-page": "1817", "volume": "51", "author": "D Ricketts", "year": "1991", "unstructured": "Ricketts, D. et al. Estrogen and progesterone receptors in the normal female breast. Cancer Res. 51, 1817\u20131822 (1991).", "journal-title": "Cancer Res."}, {"key": "41_CR33", "doi-asserted-by": "crossref", "first-page": "874", "DOI": "10.1016/S0002-9378(12)90837-6", "volume": "168", "author": "G Soderqvist", "year": "1993", "unstructured": "Soderqvist, G., von Schoultz, B., Tani, E. & Skoog, L. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle. Am. J. Obstet. Gynecol. 168, 874\u2013879 (1993).", "journal-title": "Am. J. Obstet. Gynecol."}, {"key": "41_CR34", "first-page": "4987", "volume": "57", "author": "RB Clarke", "year": "1997", "unstructured": "Clarke, R. B., Howell, A., Potten, C. S. & Anderson, E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 57, 4987\u20134991 (1997).", "journal-title": "Cancer Res."}, {"key": "41_CR35", "doi-asserted-by": "crossref", "first-page": "1795", "DOI": "10.1158/1055-9965.EPI-07-0336", "volume": "16", "author": "JR Palmer", "year": "2007", "unstructured": "Palmer, J. R., Adams-Campbell, L. L., Boggs, D. A., Wise, L. A. & Rosenberg, L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol. Biomar. Prev. 16, 1795\u20131802 (2007).", "journal-title": "Cancer Epidemiol. Biomar. Prev."}, {"key": "41_CR36", "doi-asserted-by": "crossref", "first-page": "1619", "DOI": "10.1056/NEJMoa040576", "volume": "351", "author": "M Ahlgren", "year": "2004", "unstructured": "Ahlgren, M., Melbye, M., Wohlfahrt, J. & Sorensen, T. I. Growth patterns and the risk of breast cancer in women. N. Eng. J. Med. 351, 1619\u20131626 (2004).", "journal-title": "N. Eng. J. Med."}, {"key": "41_CR37", "doi-asserted-by": "crossref", "first-page": "1183", "DOI": "10.1093/aje/kwq045", "volume": "171", "author": "HJ Baer", "year": "2010", "unstructured": "Baer, H. J., Tworoger, S. S., Hankinson, S. E. & Willett, W. C. Body fatness at young ages and risk of breast cancer throughout life. Am. J. Epidemiol. 171, 1183\u20131194 (2010).", "journal-title": "Am. J. Epidemiol."}, {"key": "41_CR38", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1002/ijc.29272", "volume": "137", "author": "H Oh", "year": "2015", "unstructured": "Oh, H. et al. The interaction between early-life body size and physical activity on risk of breast cancer. Int. J. Cancer 137, 571\u2013581 (2015).", "journal-title": "Int. J. Cancer"}, {"key": "41_CR39", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1007/s10549-007-9631-7", "volume": "109", "author": "G Samimi", "year": "2008", "unstructured": "Samimi, G., Colditz, G. A., Baer, H. J. & Tamimi, R. M. Measures of energy balance and mammographic density in the Nurses\u2019 Health Study. Breast Cancer Res. Treat. 109, 113\u2013122 (2008).", "journal-title": "Breast Cancer Res. Treat."}, {"key": "41_CR40", "doi-asserted-by": "crossref", "first-page": "2889", "DOI": "10.1158/1055-9965.EPI-05-0525", "volume": "14", "author": "HJ Baer", "year": "2005", "unstructured": "Baer, H. J. et al. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol. Biomar. Prev. 14, 2889\u20132897 (2005).", "journal-title": "Cancer Epidemiol. Biomar. Prev."}, {"key": "41_CR41", "doi-asserted-by": "crossref", "first-page": "642", "DOI": "10.1093/aje/kwr123", "volume": "174", "author": "EM Poole", "year": "2011", "unstructured": "Poole, E. M. et al. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am. J. Epidemiol. 174, 642\u2013651 (2011).", "journal-title": "Am. J. Epidemiol."}, {"key": "41_CR42", "doi-asserted-by": "crossref", "first-page": "707", "DOI": "10.1667/RR3082", "volume": "160", "author": "CE Land", "year": "2003", "unstructured": "Land, C. E. et al. Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat. Res. 160, 707\u2013717 (2003).", "journal-title": "Radiat. Res."}, {"key": "41_CR43", "doi-asserted-by": "crossref", "first-page": "342", "DOI": "10.1186/bcr318", "volume": "3", "author": "JS Lawson", "year": "2001", "unstructured": "Lawson, J. S., Field, A. S., Tran, D. D. & Houssami, N. Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women. Breast Cancer Res. 3, 342\u2013345 (2001).", "journal-title": "Breast Cancer Res."}, {"key": "41_CR44", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1002/cncr.22136", "volume": "107", "author": "LC Collins", "year": "2006", "unstructured": "Collins, L. C. et al. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses\u2019 Health Study. Cancer 107, 1240\u20131247 (2006).", "journal-title": "Cancer"}, {"key": "41_CR45", "first-page": "115", "volume": "60", "author": "AJ Stunkard", "year": "1983", "unstructured": "Stunkard, A. J., Sorensen, T. & Schulsinger, F. Use of the Danish Adoption Register for the study of obesity and thinness. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 60, 115\u2013120 (1983).", "journal-title": "Res. Publ. Assoc. Res. Nerv. Ment. Dis."}, {"key": "41_CR46", "doi-asserted-by": "crossref", "first-page": "56", "DOI": "10.1093/oxfordjournals.aje.a116777", "volume": "138", "author": "A Must", "year": "1993", "unstructured": "Must, A., Willett, W. C. & Dietz, W. H. Remote recall of childhood height, weight, and body build by elderly subjects. Am. J. Epidemiol. 138, 56\u201364 (1993).", "journal-title": "Am. J. Epidemiol."}, {"key": "41_CR47", "doi-asserted-by": "crossref", "first-page": "2346", "DOI": "10.1002/ijc.29968", "volume": "138", "author": "JS Sisti", "year": "2016", "unstructured": "Sisti, J. S. et al. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses\u2019 health studies. Int. J. Cancer 138, 2346\u20132356 (2016).", "journal-title": "Int. J. Cancer"}, {"key": "41_CR48", "first-page": "155", "volume": "11", "author": "DC Allred", "year": "1998", "unstructured": "Allred, D. C., Harvey, J. M., Berardo, M. & Clark, G. M. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathol. 11, 155\u2013168 (1998).", "journal-title": "Modern Pathol."}, {"key": "41_CR49", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.1023/A:1006883311233", "volume": "182", "author": "GM Guglielmo Di", "year": "1998", "unstructured": "Di Guglielmo, G. M. et al. Insulin receptor internalization and signalling. Mol. Cell. Biochem. 182, 59\u201363 (1998).", "journal-title": "Mol. Cell. Biochem."}, {"key": "41_CR50", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1023/A:1006808100755", "volume": "182", "author": "PG Drake", "year": "1998", "unstructured": "Drake, P. G. & Posner, B. I. Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action. Mol. Cell. Biochem. 182, 79\u201389 (1998).", "journal-title": "Mol. Cell. Biochem."}], "container-title": ["npj Breast Cancer"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41523-017-0041-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41523-017-0041-7", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41523-017-0041-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 26]], "date-time": "2017-09-26T16:09:20Z", "timestamp": 1506442160000}, "score": 46.445454, "issued": {"date-parts": [[2017, 10, 2]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2017, 12]]}, "issue": "1"}, "alternative-id": ["41"], "URL": "http://dx.doi.org/10.1038/s41523-017-0041-7", "relation": {"cites": []}, "ISSN": ["2374-4677"], "issn-type": [{"value": "2374-4677", "type": "electronic"}], "article-number": "39"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:59:00Z", "timestamp": 1574690340012}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2014, 10, 1]]}, "DOI": "10.1158/1538-7445.am2014-4685", "type": "proceedings-article", "created": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T21:52:38Z", "timestamp": 1430517158000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Abstract 4685: Caffeine and caffeic acid inhibit growth and modify estrogen receptor (ER)-\u03b1 and insulin-like growth factor I receptor (IGF-IR) levels in human breast cancer"], "prefix": "10.1158", "author": [{"given": "Ann H.", "family": "Rosendahl", "sequence": "first", "affiliation": []}, {"given": "Claire M.", "family": "Perks", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Markkula", "sequence": "additional", "affiliation": []}, {"given": "Maria", "family": "Simonsson", "sequence": "additional", "affiliation": []}, {"given": "Carsten C.", "family": "Rose", "sequence": "additional", "affiliation": []}, {"given": "Christian", "family": "Ingvar", "sequence": "additional", "affiliation": []}, {"given": "Jeff M.", "family": "Holly", "sequence": "additional", "affiliation": []}, {"given": "Helena", "family": "Jernstr\u00f6m", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 9, 30]]}, "event": {"name": "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA"}, "container-title": ["Clinical Research (Excluding Clinical Trials)"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2014-4685", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T15:48:37Z", "timestamp": 1558194517000}, "score": 45.91604, "issued": {"date-parts": [[2014, 9, 30]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2014-4685"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2014-4685"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T03:17:53Z", "timestamp": 1574219873276}, "reference-count": 21, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 7, 11]], "date-time": "2006-07-11T00:00:00Z", "timestamp": 1152576000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res"], "published-print": {"date-parts": [[2006, 8]]}, "DOI": "10.1186/bcr1520", "type": "journal-article", "created": {"date-parts": [[2006, 7, 11]], "date-time": "2006-07-11T18:15:26Z", "timestamp": 1152641726000}, "source": "Crossref", "is-referenced-by-count": 12, "title": ["Stop! In the name of transforming growth factor-\u03b2: keeping estrogen receptor-\u03b1-positive mammary epithelial cells from proliferating"], "prefix": "10.1186", "volume": "8", "author": [{"given": "Sandra L", "family": "Grimm", "sequence": "first", "affiliation": []}, {"given": "Jeffrey M", "family": "Rosen", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 7, 11]]}, "reference": [{"key": "1488_CR1", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1016/S0002-9440(10)62985-9", "volume": "167", "author": "KB Ewan", "year": "2005", "unstructured": "Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL, Barcellos-Hoff MH: Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor \u03b21 in adult mice. Am J Pathol. 2005, 167: 409-417.", "journal-title": "Am J Pathol"}, {"key": "1488_CR2", "doi-asserted-by": "publisher", "first-page": "2081", "DOI": "10.1016/S0002-9440(10)61158-3", "volume": "160", "author": "KB Ewan", "year": "2002", "unstructured": "Ewan KB, Shyamala G, Ravani SA, Tang Y, Akhurst R, Wakefield L, Barcellos-Hoff MH: Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol. 2002, 160: 2081-2093.", "journal-title": "Am J Pathol"}, {"key": "1488_CR3", "first-page": "4987", "volume": "57", "author": "RB Clarke", "year": "1997", "unstructured": "Clarke RB, Howell A, Potten CS, Anderson E: Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res. 1997, 57: 4987-4991.", "journal-title": "Cancer Res"}, {"key": "1488_CR4", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1023/A:1006186719322", "volume": "53", "author": "J Russo", "year": "1999", "unstructured": "Russo J, Ao X, Grill C, Russo IH: Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat. 1999, 53: 217-227. 10.1023/A:1006186719322.", "journal-title": "Breast Cancer Res Treat"}, {"key": "1488_CR5", "first-page": "359", "volume": "14", "author": "TN Seagroves", "year": "2000", "unstructured": "Seagroves TN, Lydon JP, Hovey RC, Vonderhaar BK, Rosen JM: C/EBP\u03b2 (CCAAT/enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol. 2000, 14: 359-368. 10.1210/me.14.3.359.", "journal-title": "Mol Endocrinol"}, {"key": "1488_CR6", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/S0040-8166(02)00024-1", "volume": "34", "author": "AV Capuco", "year": "2002", "unstructured": "Capuco AV, Ellis S, Wood DL, Akers RM, Garrett W: Postnatal mammary ductal growth: three-dimensional imaging of cell proliferation, effects of estrogen treatment, and expression of steroid receptors in prepubertal calves. Tissue Cell. 2002, 34: 143-154. 10.1016/S0040-8166(02)00024-1.", "journal-title": "Tissue Cell"}, {"key": "1488_CR7", "doi-asserted-by": "publisher", "first-page": "5076", "DOI": "10.1073/pnas.95.9.5076", "volume": "95", "author": "C Brisken", "year": "1998", "unstructured": "Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA: A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA. 1998, 95: 5076-5081. 10.1073/pnas.95.9.5076.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1488_CR8", "doi-asserted-by": "publisher", "first-page": "2196", "DOI": "10.1073/pnas.0510974103", "volume": "103", "author": "S Mallepell", "year": "2006", "unstructured": "Mallepell S, Krust A, Chambon P, Brisken C: Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA. 2006, 103: 2196-2201. 10.1073/pnas.0510974103.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "1488_CR9", "doi-asserted-by": "crossref", "first-page": "881", "DOI": "10.1096/fj.01-0885fje", "volume": "16", "author": "D Medina", "year": "2002", "unstructured": "Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL: Biological and genetic properties of the p53 null preneoplastic mammary epithelium. FASEB J. 2002, 16: 881-883.", "journal-title": "FASEB J"}, {"key": "1488_CR10", "doi-asserted-by": "publisher", "first-page": "1811", "DOI": "10.1016/S0002-9440(10)65498-3", "volume": "155", "author": "BS Shoker", "year": "1999", "unstructured": "Shoker BS, Jarvis C, Clarke RB, Anderson E, Hewlett J, Davies MP, Sibson DR, Sloane JP: Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol. 1999, 155: 1811-1815.", "journal-title": "Am J Pathol"}, {"key": "1488_CR11", "doi-asserted-by": "publisher", "first-page": "353", "DOI": "10.1007/BF02017391", "volume": "1", "author": "MH Barcellos-Hoff", "year": "1996", "unstructured": "Barcellos-Hoff MH: Latency and activation in the control of TGF-\u03b2. J Mammary Gland Biol Neoplasia. 1996, 1: 353-363. 10.1007/BF02017391.", "journal-title": "J Mammary Gland Biol Neoplasia"}, {"key": "1488_CR12", "doi-asserted-by": "publisher", "first-page": "802", "DOI": "10.1038/nm0798-802", "volume": "4", "author": "B Tang", "year": "1998", "unstructured": "Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ, Wakefield LM: Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med. 1998, 4: 802-807. 10.1038/nm0798-802.", "journal-title": "Nat Med"}, {"key": "1488_CR13", "doi-asserted-by": "publisher", "first-page": "23", "DOI": "10.1111/j.1749-6632.2001.tb02725.x", "volume": "952", "author": "D Medina", "year": "2001", "unstructured": "Medina D, Sivaraman L, Hilsenbeck SG, Conneely O, Ginger M, Rosen J, Omalle BW: Mechanisms of hormonal prevention of breast cancer. Ann NY Acad Sci. 2001, 952: 23-35.", "journal-title": "Ann NY Acad Sci"}, {"key": "1488_CR14", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1038/sj.onc.1208185", "volume": "24", "author": "CA Boulanger", "year": "2005", "unstructured": "Boulanger CA, Wagner KU, Smith GH: Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-\u03b21 expression. Oncogene. 2005, 24: 552-560. 10.1038/sj.onc.1208185.", "journal-title": "Oncogene"}, {"key": "1488_CR15", "doi-asserted-by": "publisher", "first-page": "2264", "DOI": "10.1038/sj.onc.1204312", "volume": "20", "author": "CA Boulanger", "year": "2001", "unstructured": "Boulanger CA, Smith GH: Reducing mammary cancer risk through premature stem cell senescence. Oncogene. 2001, 20: 2264-2272. 10.1038/sj.onc.1204312.", "journal-title": "Oncogene"}, {"key": "1488_CR16", "doi-asserted-by": "publisher", "first-page": "36301", "DOI": "10.1074/jbc.M508167200", "volume": "280", "author": "SL Grimm", "year": "2005", "unstructured": "Grimm SL, Contreras A, Barcellos-Hoff MH, Rosen JM: Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBP\u03b2)-null mice. J Biol Chem. 2005, 280: 36301-36309. 10.1074/jbc.M508167200.", "journal-title": "J Biol Chem"}, {"key": "1488_CR17", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1101/gad.8.1.9", "volume": "8", "author": "K Polyak", "year": "1994", "unstructured": "Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994, 8: 9-22.", "journal-title": "Genes Dev"}, {"key": "1488_CR18", "doi-asserted-by": "publisher", "first-page": "794", "DOI": "10.1128/MCB.21.3.794-810.2001", "volume": "21", "author": "JS Foster", "year": "2001", "unstructured": "Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J: Multi-faceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol. 2001, 21: 794-810. 10.1128/MCB.21.3.794-810.2001.", "journal-title": "Mol Cell Biol"}, {"key": "1488_CR19", "unstructured": "Lee WR, Chen CC, Liu S, Safe S: 17\u03b2-estradiol (E2) induces cdc25A gene expression in breast cancer cells by genomic and non-genomic pathways. J Cell Biochem."}, {"key": "1488_CR20", "doi-asserted-by": "publisher", "first-page": "3338", "DOI": "10.1128/MCB.25.8.3338-3347.2005", "volume": "25", "author": "D Ray", "year": "2005", "unstructured": "Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF, et al: Transforming growth factor \u03b2 facilitates \u03b2-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol. 2005, 25: 3338-3347. 10.1128/MCB.25.8.3338-3347.2005.", "journal-title": "Mol Cell Biol"}, {"key": "1488_CR21", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1023/B:JOMG.0000023589.00994.5e", "volume": "9", "author": "A Alkarain", "year": "2004", "unstructured": "Alkarain A, Jordan R, Slingerland J: p27 deregulation in breast cancer: prognostic significance and implications for therapy. J Mammary Gland Biol Neoplasia. 2004, 9: 67-80. 10.1023/B:JOMG.0000023589.00994.5e.", "journal-title": "J Mammary Gland Biol Neoplasia"}], "container-title": ["Breast Cancer Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/bcr1520.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/bcr1520/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/bcr1520.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 19]], "date-time": "2019-04-19T23:55:23Z", "timestamp": 1555718123000}, "score": 45.508453, "issued": {"date-parts": [[2006, 7, 11]]}, "references-count": 21, "journal-issue": {"published-print": {"date-parts": [[2006, 8]]}, "issue": "4"}, "alternative-id": ["1488"], "URL": "http://dx.doi.org/10.1186/bcr1520", "relation": {"cites": []}, "ISSN": ["1465-542X"], "issn-type": [{"value": "1465-542X", "type": "electronic"}], "article-number": "106"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T02:48:49Z", "timestamp": 1575254929379}, "reference-count": 0, "publisher": "Worldwide Protein Data Bank", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.2210/pdb5u8r/pdb", "type": "component", "created": {"date-parts": [[2018, 2, 27]], "date-time": "2018-02-27T19:04:25Z", "timestamp": 1519758265000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Structure of the ectodomain of the human Type 1 insulin-like growth factor receptor"], "prefix": "10.2210", "author": [{"given": "M.", "family": "Lawrence", "sequence": "first", "affiliation": []}, {"given": "Y.", "family": "Xu", "sequence": "additional", "affiliation": []}], "member": "7763", "published-online": {"date-parts": [[2018, 2, 28]]}, "deposited": {"date-parts": [[2019, 9, 30]], "date-time": "2019-09-30T23:10:47Z", "timestamp": 1569885047000}, "score": 45.427746, "issued": {"date-parts": [[2018, 2, 28]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2210/pdb5u8r/pdb"}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}